<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Hum Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Hum Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Human Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1662-5161</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25505396</article-id><article-id pub-id-type="pmc">4244863</article-id><article-id pub-id-type="doi">10.3389/fnhum.2014.00943</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Clinical Trial Article</subject></subj-group></subj-group></article-categories><title-group><article-title>Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Christiansen</surname><given-names>Hanna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/124409"/></contrib><contrib contrib-type="author"><name><surname>Reh</surname><given-names>Verena</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/179615"/></contrib><contrib contrib-type="author"><name><surname>Schmidt</surname><given-names>Martin H.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/195050"/></contrib><contrib contrib-type="author"><name><surname>Rief</surname><given-names>Winfried</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://community.frontiersin.org/people/u/194894"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Psychology, Child and Adolescent Psychology, Philipps-University Marburg</institution><country>Marburg, Germany</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Psychology, Clinical Psychology, Philipps-University Marburg</institution><country>Marburg, Germany</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Hartmut Heinrich, University of Erlangen-N&#x000fc;rnberg, Germany</p></fn><fn fn-type="edited-by"><p>Reviewed by: Petra Studer, University Hospital of Erlangen, Germany; Maite Ferrin, Institute of Psychiatry, UK</p></fn><corresp id="fn001">*Correspondence: Hanna Christiansen, Department of Psychology, Child and Adolescent Psychology, Philipps-University Marburg, Gutenbergstr. 18, 35037 Marburg, Germany e-mail: <email xlink:type="simple">christih@staff.uni-marburg.de</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to the journal Frontiers in Human Neuroscience.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>8</volume><elocation-id>943</elocation-id><history><date date-type="received"><day>19</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>05</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Christiansen, Reh, Schmidt and Rief.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background</bold>: Treatment for children with attention deficit/hyperactivity disorder (ADHD) today is predominantly pharmacological. While it is the most common treatment, it might not always be the most appropriate one. Moreover, long term effects remain unclear. Behavior therapy (BT) and non-pharmacological treatments such as neurofeedback (NF) are promising alternatives, though there are no routine outpatient care/effectiveness studies yet that have included children with medication or changes in medication.</p><p><bold>Methods/design</bold>: This paper presents the protocol of a randomized controlled trial to compare the effectiveness of a Slow Cortical Potential (SCP) NF protocol with self-management (SM) in a high frequent outpatient care setting. Both groups (NF/SM) receive a total of 30 high frequent therapy sessions. Additionally, 6 sessions are reserved for comorbid problems. The primary outcome measure is the reduction of ADHD core symptoms according to parent and teacher ratings.</p><p><bold>Preliminary Results</bold>: Untill now 58 children were included in the study (48 males), with a mean age of 8.42 (1.34) years, and a mean IQ of 110 (13.37). Conners-3 parent and teacher ratings were used to estimate core symptom change. Since the study is still ongoing, and children are in different study stages, pre-post and follow-up results are not yet available for all children included. Preliminary results suggest overall good pre-post effects, though. For parent and teacher ratings an ANOVA with repeated measures yielded overall satisfying pre-post effects (<italic>&#x003b7;</italic><sup>2</sup> 0.175&#x02013;0.513). Differences between groups (NF vs. SM) could not yet be established (<italic>p</italic> = 0.81).</p><p><bold>Discussion</bold>: This is the first randomized controlled trial to test the effectiveness of a NF protocol in a high frequent outpatient care setting that does not exclude children on or with changes in medication. First preliminary results show positive effects. The rationale for the trial, the design, and the strengths and limitations of the study are discussed.</p><p><bold>Trial registration</bold>: This trial is registered in <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link> as NCT01879644.</p></abstract><kwd-group><kwd>ADHD</kwd><kwd>neurofeedback</kwd><kwd>self-management</kwd><kwd>slow cortical potential training</kwd><kwd>behavior therapy</kwd><kwd>effectiveness</kwd></kwd-group><counts><fig-count count="2"/><table-count count="4"/><equation-count count="16"/><ref-count count="113"/><page-count count="15"/><word-count count="12301"/></counts></article-meta></front><body><sec id="s1"><title>Background</title><p>For children with Attention Deficit/Hyperactivity Disorder (ADHD) the European guidelines recommend a multimodal treatment (Graham et al., <xref rid="B37" ref-type="bibr">2011</xref>), as well as the new German guidelines that recommend a treatment with medication only if other treatments are not effective.<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> While this is recommended, this seems not be the reality in clinical practice. The treatment for children with ADHD today is predominantly pharmacological, with increasing prescription rates for psycho-stimulants (Barbaresi et al., <xref rid="B10" ref-type="bibr">2002</xref>; Dalsgaard et al., <xref rid="B20" ref-type="bibr">2013</xref>; Steinhausen and Bisgaard, <xref rid="B98" ref-type="bibr">2014</xref>). it is the most common treatment and with respect to short terms the most effective one for the majority of children with ADHD (Van der Oord et al., <xref rid="B112" ref-type="bibr">2008</xref>), it might not always be the most appropriate one, due to possible non-response, side-effects, or parental preferences (Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>). Moreover, long term effects remain unclear. About one third of the children treated with stimulants does not respond (Du Paul et al., <xref rid="B29" ref-type="bibr">1998</xref>; Monastra et al., <xref rid="B65" ref-type="bibr">2005</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>), adverse medication side effects such as insomnia, and decreased appetite are often reported (U.S. Department of Health and Human Services, <xref rid="B109" ref-type="bibr">1999</xref>; Schachter et al., <xref rid="B87" ref-type="bibr">2001</xref>; Graham et al., <xref rid="B37" ref-type="bibr">2011</xref>), and improvement often seems not to be maintained after treatment discontinuation (Swanson et al., <xref rid="B103" ref-type="bibr">2001</xref>; Abikoff et al., <xref rid="B1" ref-type="bibr">2004a</xref>,<xref rid="B2" ref-type="bibr">b</xref>; Molina et al., <xref rid="B64" ref-type="bibr">2009</xref>). Of the children treated with psycho-stimulants, 44&#x02013;75% do not satisfactorily profit from this treatment in long-term follow-up (MTA Cooperative Group, <xref rid="B68" ref-type="bibr">1999</xref>; Swanson et al., <xref rid="B103" ref-type="bibr">2001</xref>; Molina et al., <xref rid="B64" ref-type="bibr">2009</xref>; Nieweg, <xref rid="B70" ref-type="bibr">2010</xref>), and protective long-term effects, i.e., on substance abuse (Molina et al., <xref rid="B64" ref-type="bibr">2009</xref>, <xref rid="B63" ref-type="bibr">2013</xref>), or on academic achievement, social and interpersonal skills could not consistently be established (Whalen and Henker, <xref rid="B114" ref-type="bibr">1991</xref>; Greenhill et al., <xref rid="B38" ref-type="bibr">1999</xref>; Molina et al., <xref rid="B64" ref-type="bibr">2009</xref>; van de Loo-Neus et al., <xref rid="B111" ref-type="bibr">2011</xref>; Mrug et al., <xref rid="B67" ref-type="bibr">2012</xref>). Accordingly, some families are hesitant about medication treatment (Visser and Lesesne, <xref rid="B113" ref-type="bibr">2003</xref>; Berger et al., <xref rid="B11" ref-type="bibr">2008</xref>), and treatment alternatives are warranted.</p><p>Behavior therapy (BT) and non-pharmacological treatments such as neurofeedback (NF) are promising and supposedly side effect free alternatives (Molina et al., <xref rid="B64" ref-type="bibr">2009</xref>; Moriyama et al., <xref rid="B66" ref-type="bibr">2012</xref>). Evidence suggests positive short-term effects for different NF protocols (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>), and there is also some, though sparse evidence for long-term effects (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>). While the efficacy as well as the need for these approaches are still discussed controversely (Jensen et al., <xref rid="B45" ref-type="bibr">2007</xref>; Swanson et al., <xref rid="B102" ref-type="bibr">2008</xref>; Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>), recent quantitative reviews and meta-analyses have shed light on the efficacy of non-pharmacological treatments for ADHD (Van der Oord et al., <xref rid="B112" ref-type="bibr">2008</xref>; Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>; Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>; Moriyama et al., <xref rid="B66" ref-type="bibr">2012</xref>; Sonuga-Barke et al., <xref rid="B96" ref-type="bibr">2013</xref>; Hodgson et al., <xref rid="B40" ref-type="bibr">2014</xref>). Overall, those reviews and meta-analyses report robust medium to large effect sizes for non-pharmacological interventions on ADHD (Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>; Hodgson et al., <xref rid="B40" ref-type="bibr">2014</xref>) as well as for NF protocols (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>, <xref rid="B8" ref-type="bibr">2014</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>; Moriyama et al., <xref rid="B66" ref-type="bibr">2012</xref>; Hodgson et al., <xref rid="B40" ref-type="bibr">2014</xref>; Liew, <xref rid="B56" ref-type="bibr">2014</xref>). The meta-analysis by Sonuga-Barke et al. (<xref rid="B96" ref-type="bibr">2013</xref>) differentiates findings for NF and behavioral interventions, demonstrating larger and significant effects by raters closest to the therapeutic setting, but diminishing and non-significant effects for both interventions when probably blinded assessment (i.e., teacher ratings) was employed. Since blinded assessment was overall rare in the studies included, and reduced the already small numbers of studies subjected to meta-analysis further (from <italic>k</italic> = 8 NF studies to <italic>k</italic> = 4 with probably blinded assessment; and from <italic>k</italic> = 9 behavioral intervention studies to <italic>k</italic> = 5 with probably blinded assessment), those results should be interpreted with respect to this. More studies with higher quality and more objective outcome measures are thus warranted, though subjective improvements of parents and children are not unimportant, since an association between a positive parent-child interaction and a better outcome has been observed previously (Schachar et al., <xref rid="B86" ref-type="bibr">1987</xref>; Taylor et al., <xref rid="B105" ref-type="bibr">1991</xref>, <xref rid="B104" ref-type="bibr">1996</xref>; Tully et al., <xref rid="B107" ref-type="bibr">2004</xref>; Drabick et al., <xref rid="B25" ref-type="bibr">2006</xref>; Christiansen et al., <xref rid="B14" ref-type="bibr">2010</xref>).</p><p>As Lofthouse et al. (<xref rid="B57" ref-type="bibr">2012</xref>, p. 366) admit, blinding in psychotherapy studies is harder compared to medication studies, since knowledge of the treatment is required for a therapist and makes a placebo condition virtually impossible (see also Zuberer et al. in this Frontiers Research Topic). Nevertheless, two pilot-studies report on EEG NF double-blind randomized placebo controlled trials. Both demonstrated feasibility, but no differences between the active and placebo condition, yet (Lansbergen et al., <xref rid="B52" ref-type="bibr">2011</xref>; Arnold et al., <xref rid="B5" ref-type="bibr">2012</xref>). The eight existing studies using triple blinding in NF protocols are also inconclusive. Four of them report significant positive effects of medium to large size (DeBeus, <xref rid="B21" ref-type="bibr">2006</xref>; Leins et al., <xref rid="B54" ref-type="bibr">2006</xref>; Picard et al., <xref rid="B73" ref-type="bibr">2006</xref>; DeBeus and Kaiser, <xref rid="B22" ref-type="bibr">2011</xref>), whereas the four more recent ones report negative results (Logemann et al., <xref rid="B58" ref-type="bibr">2010</xref>; Perreau-Linck et al., <xref rid="B71" ref-type="bibr">2010</xref>; Lansbergen et al., <xref rid="B52" ref-type="bibr">2011</xref>; Arnold et al., <xref rid="B5" ref-type="bibr">2012</xref>). Moriyama et al. (<xref rid="B66" ref-type="bibr">2012</xref>, p 592), criticize, that the negative findings of those four studies &#x0201c;might have been determined by the use of suboptimal NF, because all of these studies used very experimental protocols and in none of them, the principals of learning theory were applied to ensure that subjects were really under conditioning procedures&#x0201d;. This is a key element, though, since in NF protocols operant conditioning procedures are applied to help participants learn to gain self-control over EEG patterns that are associated with attentional processes (Heinrich et al., <xref rid="B39" ref-type="bibr">2007</xref>; Gevensleben et al., <xref rid="B35" ref-type="bibr">2009b</xref>). Conditioning failures will thus be related to negative outcomes, since core principals of the therapy are then in question (for the combination of NF and behavioral therapeutic aspects see also Vollebregt et al. in this Frontiers Research Topic).</p><p>One study compared a NF slow cortical potential (SCP) protocol with BT (Drechsler et al., <xref rid="B26" ref-type="bibr">2007</xref>). In the study, NF SCP in a single setting (20 high frequent 90 min sessions in 2 weeks with a further 5 weekly/twice weekly 90 min sessions after a 5 week break) is compared with a group therapy (total of 15 ninety minute sessions weekly to twice weekly) based on behavioral interventions such as self-management (SM) and parent training, demonstrating more pronounced treatment effects for the NF SCP group. But the total number of sessions (NF SCP: 25 vs. BT: 15), the setting (NF SCP: single vs. BT: group), frequency (NF SCP: dayly vs. BT: weekly/twice weekly), and duration of the two interventions are not comparable, hampering conclusions with respect to the efficacy of the interventions. A more recent study by Garcia et al. (see this Frontiers Research Topic) compares 57 children with ADHD that were randomly assigned to three different treatments: NF theta/beta training sessions, methylphenidate treatment, and BT. Their results reveal specific changes in EEG variables, specifically related to NF theta/beta training; results on ADHD symptoms are not reported, yet.</p></sec><sec id="s2"><title>Aims of the trial</title><p>The aim of the present study is to establish whether a NF protocol under outpatient care conditions is at least as effective as an approved and established behavioral treatment (SM), as results in the Drechsler et al. (<xref rid="B26" ref-type="bibr">2007</xref>) study suggest. The current study is designed to compare a SCP NF training with a behavioral SM training (SM: Lauth and Schlottke, <xref rid="B53" ref-type="bibr">2009</xref>). To date, NF is not yet approved as a psychotherapeutic intervention by health care providers in Germany, and to our knowledge there is no effectiveness study investigating the feasibility and effects of NF under regular outpatient care conditions.</p><p>We are thus interested in whether NF (SCP training) is a true treatment alternative to behavioral interventions that are approved by health care providers. Since the studies so far were experimental ones establishing effects of NF protocols that did not allow medication or changes in medication, this question is not answered, yet.</p><p>The primary research question is:</p><list list-type="order"><list-item><p>Is a SCP NF protocol under outpatient care conditions at least as effective as an approved and established behavioral treatment (SM) at the end of treatment, and at six and twelve months follow-up?</p></list-item></list><p>Further examination of secondary research questions</p><list list-type="order"><list-item><p>EEG-patterns:</p><p>Does NF result in specific changes of EEG patterns compared to SM? Are there specific associations between neuroregulation skills and clinical outcomes?</p></list-item><list-item><p>Child outcomes:</p><p>Do both treatments (NF and SM) improve children&#x02019;s executive functions, quality of life, self-concept and school grades? And is treatment response in both treatments moderated by children&#x02019;s perceived social support?</p></list-item><list-item><p>Parent outcomes:</p><p>Do both treatments (NF and SM) improve parenting skills, parental perceived social support and expressed emotion (EE)? Does the parent group with additional social support (PE + SU) show enhanced social support after treatment and more positivity and warmth towards the child compared to the group with PE only? Is this moderated by comorbidity?</p></list-item></list></sec><sec sec-type="methods" id="s3"><title>Methods</title><sec id="s3-1"><title>Participants</title><sec id="s3-1-1"><title>Inclusion criteria</title><p>The study is performed with children either newly diagnosed with ADHD or with verified diagnoses. Participants are children referred for ADHD treatment either by their parents, pediatricians, or psychiatrists. To be eligible for the study, the children have to meet the following inclusion criteria: aged seven to eleven, full command of the German language, current DSM-IV diagnosis of ADHD (either combined, predominantly inattentive or predominantly hyperactive/impulsive subtype), IQ &#x02265;80 (short version of the WISC; information, picture arrangement, similarities and block-design; Sattler, <xref rid="B85" ref-type="bibr">2008</xref>, p. 186). Children with comorbid disorders are not excluded from the study, and behavioral treatment of comorbid conditions is included in the treatment plan. The rational for this is based on the effectiveness design of the study. The majority of the children with ADHD presents with comorbid disorders (Kadesj&#x000f6; et al., <xref rid="B46" ref-type="bibr">2003</xref>; Willcutt et al., <xref rid="B115" ref-type="bibr">2005</xref>; Gadow et al., <xref rid="B33" ref-type="bibr">2006</xref>; Jakobson and Kikas, <xref rid="B44" ref-type="bibr">2007</xref>; Anney et al., <xref rid="B3" ref-type="bibr">2008</xref>; Semrud-Clikeman and Bledsoe, <xref rid="B91" ref-type="bibr">2011</xref>; Stein et al., <xref rid="B97" ref-type="bibr">2011</xref>; Vakil et al., <xref rid="B110" ref-type="bibr">2012</xref>), and parents and children seeking help in our outpatient clinic request treatment of all impairing problems, and not just ADHD (please refert to the preliminary result section for information on comorbidities). The children under stimulant medication are also not excluded from the study, but dose and possible changes will be recorded.</p></sec><sec id="s3-1-2"><title>Exclusion criteria</title><p>Children with symptoms of inattention, hyperactivity or impulsivity due to other medical reasons such as hyperthyreosis, autism, epilepsy, brain disorders and any genetic or medical disorder associated with externalizing behavior.</p></sec></sec><sec id="s3-2"><title>Design and procedure</title><sec id="s3-2-1"><title>Recruitment and consent</title><p>The Psychotherapeutic Outpatient Clinic of the Department of Psychology, Clinical Psychology, at the University of Marburg treats children, adolescents and adults with psychological disorders. Patients can refer themselves or are referred by their pediatricians, psychiatrists, or general practitioners. Parents and children interested in the study are sent a full study description with separate information for parents, teachers, and children, and Conners-3 questionnaires for parents and teachers as well as questions on demographics and therapy expectations. Screen positive patients are invited for a semi-structured diagnostic interview (Kiddie-Sads-Present and Lifetime Version; K-SADS-PL; Kaufman et al., <xref rid="B47" ref-type="bibr">1996</xref>) with a licensed child and adolescent psychotherapist to assess ADHD and possible comorbid disorders. If ADHD is diagnosed, the patient and his/her parents are informed about the treatment options and receive oral information based on the written information already sent out to the families. If the child fulfills diagnostic criteria and the family wants to participate in the study, informed consent is signed by the parents and their children, and further diagnostic assessments are scheduled.</p></sec><sec id="s3-2-2"><title>Randomization and treatment allocation</title><p>The children are randomized to receive either NF or SM training. Parents of children are randomized to parent training groups with either psychoeducation only (PE), or PE enhanced with additional social support (PE+SU). Treatment allocation is performed by computer programming stratified for gender and stimulant medication. In this way, we aim to ensure that trial arms are balanced with respect to the baseline characteristics gender and use of ADHD medication. Patients, parents, therapists, and investigators were not blinded for the treatment allocation. Teachers are blind with respect to treatment allocation.</p></sec><sec id="s3-2-3"><title>Procedure</title><p>Both the NF and SM interventions are manualized, equal in setting (single), duration, frequency, parental involvement, and supporting token economies (for details on this please refer to treatment protocols of this article). The rationale for those treatment parameters is based on the results of the available meta-analyses (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>; Esser and Blank, <xref rid="B31" ref-type="bibr">2011</xref>; Zwi et al., <xref rid="B117" ref-type="bibr">2011</xref>; Lofthouse et al., <xref rid="B57" ref-type="bibr">2012</xref>; Moriyama et al., <xref rid="B66" ref-type="bibr">2012</xref>; Sonuga-Barke et al., <xref rid="B96" ref-type="bibr">2013</xref>; Hodgson et al., <xref rid="B40" ref-type="bibr">2014</xref>). The SM training is approved and refunded by insurance providers in Germany for ADHD therapy (for the efficacy of SM trainings for ADHD see the reviews by Saile, <xref rid="B84" ref-type="bibr">1996</xref>; Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>); NF is only refunded in health care settings that also do research in the field. Since our department is a university one, it is possible to get NF training refunded by in such a setting.</p><p>Figure <xref ref-type="fig" rid="F1">1</xref> provides an overview of the trial flow. After informed consent and baseline assessment (T1), a diagnostic assessment of ADHD and possible comorbid disorders with the K-SADS-PL follows. During T1 all primary and secondary outcome measures, neuropsychological tests, and quantitative EEGs are scheduled. Children are off medication 48 h prior to all diagnostic assessments to not distort results due to treatment. The same procedure is applied for all further assessments. After confirmation of ADHD diagnosis, randomization takes place. The children in both groups then receive 24 high frequent therapy sessions (NF or SM) over twelve weeks with up to three 1 h sessions per week, since such an intensive training has proved to be highly effective (Strehl et al., <xref rid="B101" ref-type="bibr">2011</xref>). After the first twelve sessions in 4 weeks, there is a 1 week break followed by the next 4 weeks with high frequent training. After 24 sessions only Conners-3 parent ratings are used for T2 assessment and there is another break for 1 week. Additionally for both groups 6 individualized BT sessions are reserved for comorbid problems after T2 assessment. Depending on the disorder and treatment selected, those sessions might be high frequent or scheduled only weekly. After the comorbid sessions, six high frequent NF or SM follow that end the therapy. T3 assesses post-treatment effects (all primary and secondary outcomes). Five months after end of treatment, all children are offered three booster training sessions (either NF or SM according to allocation). Six (T4) and twelve months (T5) after treatment termination follow-up assessments with all primary and secondary outcome measures are scheduled. Parent groups are accompanying children&#x02019;s therapy. Table <xref ref-type="table" rid="T1">1</xref> gives a detailed overview of the treatment plan.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Flow-chart of the study</bold>. <bold>R</bold> = Randomization of parents to either PE or PE+SU.</p></caption><graphic xlink:href="fnhum-08-00943-g0001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Overview of all assessment and treatment sessions of the study</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Session</bold></th><th align="center" rowspan="1" colspan="1"><bold>Content</bold></th><th align="center" rowspan="1" colspan="1"><bold>Duration</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Outpatient assessment and informed consent; information on study participation</td><td align="left" rowspan="1" colspan="1">100 min</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Diagnostic assessment</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2&#x02013;4</td><td align="left" rowspan="1" colspan="1">Pre-assessments of all primary and secondary outcome measures (T1)</td><td align="left" rowspan="1" colspan="1">50 min per session</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Randomization of children and parents</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">Feedback of test results</td><td align="left" rowspan="1" colspan="1">50 min</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Psycho-education children</td><td align="left" rowspan="1" colspan="1">50 min</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Intervention</bold></td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Accompanying Parent Training</bold></td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">7&#x02013;18</td><td align="left" rowspan="1" colspan="1"><bold><italic>Block I:</italic></bold></td><td align="center" rowspan="1" colspan="1">50 min per session</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">High frequent NF/SM treatment over 4 weeks (12 sessions)</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold><italic>Break (1 week)</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">19&#x02013;30</td><td align="left" rowspan="1" colspan="1"><bold><italic>Block II:</italic></bold></td><td align="center" rowspan="1" colspan="1">50 min per session</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">High frequent NF/SM treatment over 4 weeks (12 sessions)</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold><italic>Break (1 week) and T2 assessment*</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">31&#x02013;36</td><td align="left" rowspan="1" colspan="1"><bold><italic>Block III&#x02014;part 1:</italic></bold></td><td align="center" rowspan="1" colspan="1">50 min per session</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Behavior therapy of comorbid problems (6 sessions)</td></tr><tr><td align="left" rowspan="1" colspan="1">37&#x02013;42</td><td align="left" rowspan="1" colspan="1"><bold><italic>Block III&#x02014;part 2:</italic></bold></td><td align="center" rowspan="1" colspan="1">50 min per session</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">High frequent NF/SM treatment (6 sessions)</td></tr><tr><td align="left" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1"><bold>Post assessment (T3)</bold></td><td align="left" rowspan="1" colspan="1"><bold>50 min</bold></td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Follow-up assessment and booster sessions</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">44&#x02013;46</td><td align="left" rowspan="1" colspan="1">3 Booster sessions ca. 5 months after treatment discontinuation</td><td align="center" rowspan="1" colspan="1">50 min per session</td></tr><tr><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">6-months follow-up (T4)</td><td align="center" rowspan="1" colspan="1">50 min</td></tr><tr><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">12-months follow-up (T5)</td><td align="center" rowspan="1" colspan="1">50 min</td></tr></tbody></table><table-wrap-foot><p><italic>*T2 assessment: only Conners 3&#x000a9; parent rating scales</italic>.</p></table-wrap-foot></table-wrap></sec></sec><sec id="s3-3"><title>Treatment protocols</title><sec id="s3-3-1"><title>Neurofeedback</title><p>Before treatment all children receive standardized PE on ADHD (Lauth and Schlottke, <xref rid="B53" ref-type="bibr">2009</xref>). For NF training in this study we use the Thera Prax<sup>&#x000ae;</sup> (NeuroConn&#x000a9;) NF system. It offers several different feedback animations and the option to upload pictures which keeps the training diversified and motivates children. During training sessions, the children take seat in a comfortable chair with a head- and armrest in front of a computer screen and are introduced to the training as kind of a computer game that helps them learn to modulate their brain activity.</p><p>We use the feedback protocol of SCP training that has been incorporated in many NF studies (Strehl et al., <xref rid="B100" ref-type="bibr">2006</xref>; Heinrich et al., <xref rid="B39" ref-type="bibr">2007</xref>; Gevensleben et al., <xref rid="B36" ref-type="bibr">2009a</xref>,<xref rid="B35" ref-type="bibr">b</xref>, <xref rid="B34" ref-type="bibr">2010</xref>; Arns et al., <xref rid="B8" ref-type="bibr">2014</xref>). The children&#x02019;s task is to generate negative and positive SCPs by getting into an attentive (negativity trials) or a relaxed state (positivity trials). The aim of the training is to steer a moving object (i.e., an airplane, a fish, a spaceship) that appears on the screen in front of them in the requested direction (arrow upwards indicates negativity trial; arrow downwards indicates positivity trial). The children can choose a training object at the beginning of each therapy session. In the transfer trials, the children do not see the object, but only the direction of the arrow. The children are instructed to sit as still as possible during the training, to avoid laughing and talking, but to concentrate on the screen in front of her/him. No specific instruction is given to the children on how to succeed in negativity or positivity trials, but just to be attentive to feedback and to find the most effective mental strategy to steer the object into the requested direction. As there is no unique strategy for NF training, the children are given examples that have been successful for some children (i.e., negativity trials: &#x0201c;Think of something you find exciting like sitting in a race car or standing on a diving board&#x0201d;; positivity trials: &#x0201c;Those strategies are used in situations requiring relaxation. Think of something you find calming and pacifying like listening to soothing music&#x0201d;). After a successful trial a sun appears on the screen (reinforcement). Additionally, a token plan is used that enables the children to earn up to 5 tokens per session if they stay attentive during the whole session. A full token plan of 15 tokens (every third session) can be exchanged into small rewards by parents that are agreed upon at the beginning of the training together with the parents and the child.</p><p>Participants in the NF condition receive a total of 30 sessions of SCP training. Each therapy session consists of three runs. One run consists of 40 trials (8 min) resulting in a total of 24 min NF training per session (see Figure <xref ref-type="fig" rid="F2">2</xref> for details). A trial lasts for 8 s (2 s baseline period, 6 s feedback period). Inter-trial interval is set to 5 &#x000b1; 1 s. Between each of the three runs there is a short break of several minutes which can be used by the therapist to motivate and praise the child and to talk about problems and use of strategies (i.e., &#x0201c;What was your strategy for negativity/positivity trials?&#x0201d;, &#x0201c;How did it work?&#x0201d;, &#x0201c;What else could you try as a negativity/positivity trial strategy?&#x0201d;). The last 10 min of each session are reserved for joint play which is an important aspect of motivating the child and strengthening the therapeutic relationship. Feedback is calculated from the vertex (Cz) and is referenced against both mastoids (bandwidth 0.01&#x02013;30 Hz, sampling rate: 256 Hz), and vertical as well as horizontal eye movements are corrected online with electrodes placed above and below the left eye, and electrodes on the right and left side of the face (4 electrooculography channels, EGO; for details of the protocol see Strehl, <xref rid="B99" ref-type="bibr">2009</xref>). Ocular artifact removal is possible with DC-EEG as described in Schlegelmilch et al. (<xref rid="B88" ref-type="bibr">2004</xref>). The ratio of negativity to positivity is set to 1:1, and negativity/positivity trials are presented in random order. All sessions start with no threshold, but if the child has a hit rate (correct responses) of &#x02265;70%, thresholds are introduced automatically. Those start with an initial 5% threshold, and are followed in steps of 5% if the child continuous to score &#x02265;70%.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Neurofeedback Protocol with three therapy blocks and a total of 30 sessions</bold>.</p></caption><graphic xlink:href="fnhum-08-00943-g0002"/></fig><p>The first two runs in every therapy session include no transfer trials, i.e., the child gets continuous visual feedback, whereas the third run is set to 100% transfer (for this rationale see also Vollebregt et al. in this Frontiers Research Topic). Although no continuous feedback is given on transfer trials, a sun appears at the end of the trials to provide information about success (reinforcement). Transfer trials are thought to support generalization to everyday life situations (Strehl et al., <xref rid="B101" ref-type="bibr">2011</xref>). Additionally, starting with the second therapy block (12th session) children are asked to practice their mental strategies in specific situations at home or school for about 10 min each day. Together with the therapist children identify situations that require attention control (i.e., negativity strategies: before starting to do homework; positivity strategies: at night before going to bed). The children are asked to document practicing by keeping a log which is controlled by the therapist at the beginning of a session (see also Vollebregt et al. in this Frontiers Research Topic). If the child practices each day between sessions he/she can earn an extra token.</p><p>In the first and second therapy block the children complete twelve NF sessions each. After those two blocks (with a 1 week break to relieve families in between; see also Strehl et al., <xref rid="B101" ref-type="bibr">2011</xref>) a block reserved for the treatment of comorbid problems follows (total of six sessions). In this block individual BT is applied for the specific comorbid conditions. Treatment of those is based on published intervention manuals. Then a final block with six NF sessions follows that ends the therapy. In this block, the ratio of negativity to positivity trials is set to 3:1.</p></sec><sec id="s3-3-2"><title>Self-management</title><p>Before treatment all children receive standardized PE as described in the NF section above. The SM training addresses children aged 6&#x02013;12 years (Lauth and Schlottke, <xref rid="B53" ref-type="bibr">2009</xref>), and is based on the self-instruction training as described in Meichenbaum and Goodman (<xref rid="B61" ref-type="bibr">1971</xref>). Goal of the training is to enhance child development in the domains behavior regulation, planning, organization, and self-reflection. A meta-analysis with <italic>k</italic> = 11 studies provides empirical evidence of the training (Lauth and Schlottke, <xref rid="B53" ref-type="bibr">2009</xref>; for the general efficacy of such treatments see the reviews by Saile, <xref rid="B84" ref-type="bibr">1996</xref>; Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>). In the first therapy block the basic training (12 sessions) is completed. This consists of the sessions (1) precise looking; (2) precise describing; (3) precise listening; (4) precise listening and re-telling; (5) precise account of perceptions; (6) introduction of the stop-signal; (7) self-contained stopping and checking; (8) accompanying checking procedures; (9) transfer of checking techniques to school contexts; (10) self-instruction with the stop signal; (11) self-instruction with difficult tasks; (12) self-instruction under distraction. After 1 week break the second therapy block follows with the strategy training: (1) basic skills; (2) signal cards; (3) thinking loud; (4) flexible use of signal cards; (5) adaptation of learned strategies for new tasks; (6) cross-linking strategies; (7) discover systematic principles; (8) adaptation of learned strategies for complex tasks; (9) solving abstract problems; (10) organizing learning strategies; (11) development of strategies for complex school tasks; (12) application of strategies for complex school tasks.</p><p>Each session (except the first one) begins with the recapitulation of the last session and an introduction into the topic of the session (10 min). This is followed by modeling the behavior that the topic of the session requires (10 min) and the child trains this for 20 min. The last 10 min are reserved for joint play to motivate the child and to build a good therapeutic relationship. A token plan is installed together with the child and the parents. As in the NF group, the children can earn up to 5 tokens per session if they stay attentive during the training unit. A full token plan of 15 tokens (every third session) can be exchanged into small rewards by parents.</p><p>To keep both therapy groups balanced, quantity of homework is kept identical. Starting in the second therapy block, the children in the SM group are asked to practice self-instruction with the stop signal during homework each day for 10 min. As in the NF group, practicing is documented in a log which is controlled by the therapist at the beginning of a session and the children can also earn an extra token for doing the homework. Differing from the NF protocol, the children do not practice relaxation, since this is not part of the SM training.</p></sec><sec id="s3-3-3"><title>Treatment of comorbid disorders</title><p>Depending on the comorbid disorder of the child, manualized behavior treatments are applied. The most common comorbid disorder in our sample so far is Oppositional Defiant Disorder (ODD). The principles to reduce such problem behaviors are based on the training manuals used in the parent PE (see below). In addition, after PE with the child token economies are also introduced to reduce ODD symptoms. Other disorders such as Tic Disorder, Enuresis, Sibling Rivalry Disorder are also treated with BT, i.e., apart from token economies, habit reversal training, alarm therapy, one to one quality time with the child (Esser, <xref rid="B30" ref-type="bibr">2011</xref>). For children without comorbid disorders, those sessions are used to resolve other conflicts that have an impairing quality, i.e., children without many friends receive social competence training.</p></sec><sec id="s3-3-4"><title>Parent training</title><sec id="s3-3-4-1"><title>Psycho-education only (PE)</title><p>Since ADHD does not only affect the child, but is specifically characterized by impairments at home and school, the parent training supports the parents and the transfer into the home setting. It is part of the training by Lauth and Schlottke (<xref rid="B53" ref-type="bibr">2009</xref>). The core element is PE with respect to ADHD, as well as development of strategies that effectively support the child. Topics are: (1) information on ADHD; (2) handling problem behavior I and introduction of token economies; (3) joint parent-child play; (4) handling problem behavior II and introduction of timeout and 1-2-3-Magic (Phelan, <xref rid="B72" ref-type="bibr">2003</xref>); (5) handling problem behavior in public. Between sessions, parents have to complete homework, training the strategies in everyday life. This homework is discussed in the following session. Therapists are the same as in the children&#x02019;s intervention. A meta-analysis supports parent trainings as this one for ADHD (Bachmann et al., <xref rid="B9" ref-type="bibr">2008</xref>; Zwi et al., <xref rid="B117" ref-type="bibr">2011</xref>). A total of five parent group sessions lasting 100 min each are scheduled accompanying children&#x02019;s therapy.</p></sec><sec id="s3-3-4-2"><title>PE + social support (SU)</title><p>Parents in this group receive PE as described above, with additional components on social support, based on network oriented interventions (R&#x000f6;hrle et al., <xref rid="B81" ref-type="bibr">1998</xref>), since a study has shown positive effects of social support on parental EEs, with parents with high social support showing more positivity and warmth towards their children, that was related to reduced comorbid oppositionality (Christiansen et al., <xref rid="B14" ref-type="bibr">2010</xref>). Parents are trained with network analyses to identify supporting social networks, and to possibly activate them. If non-supportive network characteristics are identified, modification is supported. Between sessions, parents have to complete homework as in the PE only group and additionally on individual social network analyses. For this they have to think of ways of how to activate positive social support. A total of five parent group sessions lasting 100 min each are scheduled accompanying the children&#x02019;s therapy.</p></sec></sec></sec><sec id="s3-4"><title>Therapists</title><p>All therapists are trained in both NF, SM, PE, and PE+SU and all therapists deliver all trainings based on intervention manuals. All interventions for comorbid conditions are also based on published intervention manuals. All therapists are therapists in training and receive regular supervision (every fourth session) by a licensed supervisor with more than 5 years experience in BT for the duration of the trial. To control implementation and fidelity, all sessions are videotaped and analyzed in the supervision sessions.</p></sec><sec id="s3-5"><title>Measurements</title><p>With the exception of parent and teacher questionnaires, all assessments are conducted in face-to-face contacts. Apart from the primary ADHD outcomes (change in psychopathology from baseline to post therapy) we are also interested in therapy related quantitative EEG patterns of response to NF/SM. In the existing NF studies, changes in EEG patterns have been reported after therapy (e. g.: Monastra et al., <xref rid="B65" ref-type="bibr">2005</xref>; Heinrich et al., <xref rid="B39" ref-type="bibr">2007</xref>; Gevensleben et al., <xref rid="B36" ref-type="bibr">2009a</xref>; Arns et al., <xref rid="B8" ref-type="bibr">2014</xref>; see also Garcia et al. in this Frontiers Research Topic). But, differing from the homogeneous results for parent and teacher ratings (primary outcomes), this change proved to be heterogeneous according to meta-analysis (Nestoriuc et al., <xref rid="B69" ref-type="bibr">2011</xref>). Possible changes in EEG patterns before and after therapy will thus be compared for both the NF and SM group to establish whether changes are specific for the NF group.</p><sec id="s3-5-1"><title>Selection and diagnostic measurements</title><list list-type="order"><list-item><p>Screening for the presence of ADHD symptoms is performed with the Conners 3<sup>&#x000ae;</sup> parent and teacher ratings (German version: Lidzba et al., <xref rid="B55" ref-type="bibr">2013</xref>). Clinical impairment is established with T-scores of &#x02265;60.</p></list-item><list-item><p>The DSM-IV diagnosis of ADHD and possible comorbid disorders is based on the semi-structured diagnostic interview Kiddie-Sads-Present and Lifetime Version (K-SADS-PL: Kaufman et al., <xref rid="B47" ref-type="bibr">1996</xref>).</p></list-item></list><p>The 3rd edition of the CRS (Conners 3<sup>&#x000ae;</sup>: Conners, <xref rid="B18" ref-type="bibr">2008</xref>; German version: Lidzba et al., <xref rid="B55" ref-type="bibr">2013</xref>) assess ADHD core symptoms as well as Learning Problems, Executive Functioning, Peer- and Family Relations, co-morbid conditions such as ODD and Conduct Disorder (CD) in children aged six (parent and teacher forms) and eight (self-report forms) to 18 years of age. The Conners 3<sup>&#x000ae;</sup> rating scales have been translated into German, back-translated, and norms for a German-speaking sample were established (Lidzba et al., <xref rid="B55" ref-type="bibr">2013</xref>). A study on cultural comparability of the German Conners 3<sup>&#x000ae;</sup> resulted in good model-fits for confirmatory factor analyses (Christiansen et al., submitted), and cultural comparability for a large group of Germans with Turkish migration background could also be established (Schmidt et al., <xref rid="B89" ref-type="bibr">2013</xref>), with satisfactory internal consistencies of the scales in both studies.</p><p>The K-SADS-PL (Kaufman et al., <xref rid="B47" ref-type="bibr">1996</xref>; German adaptation Delmo et al., <xref rid="B23" ref-type="bibr">2011</xref>) is a semi-structured diagnostic interview designed to assess current and past episodes of psychopathology in children and adolescents according to DSM-III-R and DSM-IV criteria. Probes and objective criteria are provided to rate individual symptoms. The interview consists of two parts. The first part is a screening interview that screens for the psychological disorders. If an item is scored with &#x0201c;3&#x0201d; (0 = no information, 1 = nonexistent, 2 = below threshold, 3 = above threshold), the full interview of this section is carried out. Diagnoses are then based on DSM criteria that are listed and scored at the end of the full interview. The K-SADS has been carefully constructed and is widely used.<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref></p></sec><sec id="s3-5-2"><title>Outcome measures</title><sec id="s3-5-2-1"><title>Parent, and/or teacher ratings</title><list list-type="order"><list-item><p>The Conners 3<sup>&#x000ae;</sup> parent and teacher scales are used as the measure of change of children&#x02019;s ADHD symptoms (see above Conners, <xref rid="B18" ref-type="bibr">2008</xref>; German adaptation Lidzba et al., <xref rid="B55" ref-type="bibr">2013</xref>). The parent and teacher scales consist of 105 and 111 items respectively that are rated on a four point Likert scale with severity ratings from 0 (not at all/never) to 3 (very much/very frequently).</p></list-item><list-item><p>The Parental Stress Inventory (Eltern-Stress-Fragebogen (ESF); Domsch and Lohaus, <xref rid="B24" ref-type="bibr">2010</xref>) assesses with 38 items the four subscales parenting stress, role restriction, social support, and partnership. Internal consistency is satisfactory (0.76&#x02013;0.92) as well as re-test reliability (0.76&#x02013;0.91). Convergent validity has been established with the Parenting Stress Index.</p></list-item><list-item><p>The Parenting Scale (PS: Arnold et al., <xref rid="B6" ref-type="bibr">1993</xref>; German version: Miller, <xref rid="B62" ref-type="bibr">2001</xref>) assesses parenting styles (reactions and strategies) for different problematic situations. The two subscales over-reacting and leniency have satisfactory internal consistency (0.75), as well as the total scale (0.76).</p></list-item><list-item><p>Start, stop and dosis of stimulant medication are monitored throughout the therapy. Since our clinic is a psychotherapeutic department, medication treatment is monitored by children&#x02019;s pediatricians or child and adolescent psychiatrist. Parents report what medication is given at what time and report on titration procedures, as well as on side-effects.</p></list-item></list></sec><sec id="s3-5-2-2"><title>Child ratings</title><list list-type="simple"><list-item><label>5.</label><p>The Qb-Test is a combined continuous performance (CPT) and activity test for children aged 6&#x02013;12 years (Ulberstad, <xref rid="B108" ref-type="bibr">2012</xref>), which aims to objectively assess all three core symptoms of ADHD in one test, and has been approved by the Food and Drug Administration (FDA) in 2012. While performing a standardized CPT on a computer, the movements of the participant are recorded with an infrared camera following a reflective marker attached to a headband that the participant wears while performing the test. Factorial validity for the test and the three core ADHD symptoms (inattention, hyperactivity, impulsivity) has been established (Reh et al., <xref rid="B77" ref-type="bibr">2013</xref>), as well as usefulness as a potential endophenotype assessment (Reh et al., <xref rid="B78" ref-type="bibr">2014</xref>).</p></list-item><list-item><label>6.</label><p>The children&#x02019;s test-battery of attention assessment (KITAP: Zimmermann et al., <xref rid="B116" ref-type="bibr">2002</xref>) assesses different attention parameters that are administered with a computer. Psychometric properties of the KITAP have been reported in different studies (Renner and Irblich, <xref rid="B79" ref-type="bibr">2007</xref>; Kaufmann et al., <xref rid="B48" ref-type="bibr">2010</xref>; R&#x000f6;thlisberger et al., <xref rid="B82" ref-type="bibr">2010</xref>; Sobeh, <xref rid="B92" ref-type="bibr">2010</xref>; Dreis&#x000f6;rner and Georgiadis, <xref rid="B28" ref-type="bibr">2011</xref>; Renner et al., <xref rid="B80" ref-type="bibr">2012</xref>) as well as clinical validity for seven to 10 year old children with ADHD (Drechsler et al., <xref rid="B27" ref-type="bibr">2009</xref>). In our study the following subtests are included: sustained attention, Go/No-Go, and divided attention.</p></list-item><list-item><label>7.</label><p>The Child and Adolescent Social Support Scale (CASSS: Malecki et al., <xref rid="B60" ref-type="bibr">1999</xref>) is a 40-item multidimensional scale measuring perceived social support from four sources: parents, teachers, classmates, and friends. Frequency ratings consist of a 6-point Likert Scale from 1 (Never) to 6 (Always). Importance ratings consist of a 3-point Likert Scale ranging from 1 (Not Important) to 3 (Very Important). Each subscale corresponds to one of the sources of support (e.g., parent, teacher, classmate, and close friend) and consists of 10 items. Subscale scores are calculated by summing the frequency ratings on the 10 items on each subscale. Analyses revealed evidence of reliability, a four-factor structure (Parent, Teacher, Classmate, and Close Friend subscales), and construct validity. The CASSS co-varies with the clinically important constructs of self-concept, social skills, and behavioral indicators. There is evidence that the CASSS can be used to understand children&#x02019;s and adolescents&#x02019; perceived social support (Malecki and Demaray, <xref rid="B59" ref-type="bibr">2002</xref>).</p></list-item><list-item><label>8.</label><p>The self-concept interview (Sch&#x000f6;ning et al., <xref rid="B90" ref-type="bibr">2002</xref>) is a structured interview. Self-concept is assessed for school, family, and peer-relations. The following categories are rated and coping abilities are assessed: social interactions, perceived quality of life and self-worth. Items are formulated in a way that they do not confound with core ADHD symptoms. Internal consistency is satisfactory (range 0.70&#x02013;0.83; overall 0.85).</p></list-item><list-item><label>9.</label><p>The KINDL-R (Ravens-Sieberer et al., <xref rid="B74" ref-type="bibr">2003</xref>) assesses health related quality of life of children and adolescents. Both parents and children rate the six dimensions physical well-being, emotional well-being, self-worth, family related well-being, peer related well-being and school related well-being. A total of 24 items is to be rated on a 5-point Likert scale from 0 = never to 4 = often. Internal consistency is satisfactory (0.85 for the total scale, all subscales &#x02265;0.70), and the questionnaire has been used in various studies with children (Ravens-Sieberer and Bullinger, <xref rid="B75" ref-type="bibr">1998a</xref>,<xref rid="B76" ref-type="bibr">b</xref>).</p></list-item><list-item><label>10.</label><p>The Perceived Criticism Scale (PC) consists of the item &#x0201c;How critical is your spouse of you&#x0201d; to be rated on 10-point Likert scale from 0 = not at all critical to 10 = very critical indeed. Originally the item was used by Hooley (<xref rid="B42" ref-type="bibr">1990</xref>) to assess high EE, i.e., hostility, criticism, and emotional over-involvement, in spouses of patients with depression. With 40% variance explained, this item was the strongest predictor of relapse in a 9 months follow-up. The item has been translated into German and was adapted for children (How much does your mum/dad like you?). This version has already been successfully used with children with and without ADHD (Christiansen et al., <xref rid="B14" ref-type="bibr">2010</xref>).</p></list-item><list-item><label>11.</label><p>Quantitative EEGs are assessed for both NF and SM groups before therapy (T1), and post therapy (t3) as well as at six (t4) and twelve (t5) months follow-up to establish whether NF training results in changes specific for NF.</p></list-item></list></sec></sec><sec id="s3-5-3"><title>Primary and secondary outcome measures</title><p>The primary outcome measure is defined as the change of ADHD hyperacitivity, inattention, and impulsivity symptoms according to parent and teacher Conners 3<sup>&#x000ae;</sup> ratings (DSM-IV subscales and Conners&#x02019;-ADHD-Index; Conners, <xref rid="B18" ref-type="bibr">2008</xref>; German version: Lidzba et al., <xref rid="B55" ref-type="bibr">2013</xref>) at the end of the treatment (T3) compared to T1. To establish stability of effects, T3 assessments will be compared to six (T4) and 12 (T5) months follow-up assessments. T2 assessment (after the first therapy block) will be used to establish effects compared to T1 without the treatment of comorbid disorders.</p><p>Key secondary outcome measure is percentage of treatment responders (defined as a reduction of at least 30% of ADHD symptoms according to Conners-3 ratings of parents and teachers) at the end of treatment and at follow-ups. Qb-Test (Ulberstad, <xref rid="B108" ref-type="bibr">2012</xref>; Reh et al., <xref rid="B77" ref-type="bibr">2013</xref>), and KITAP (Zimmermann et al., <xref rid="B116" ref-type="bibr">2002</xref>) scores objectively assessing core ADHD-symptoms and executive functions at follow-ups are further key secondary outcome measures at the end of treatment (T3).</p><p>Other secondary outcome measures are changes in quantitative EEG patterns as well as changes in scores of self-concept, the KINDL-R, PC, ESF, PS at the end of treatment and follow-ups.</p></sec></sec><sec id="s3-6"><title>Statistical analyses</title><p>Data will be analyzed according to the intent-to-treat (ITT) principle, thus patients will be analyzed according to the randomization scheme. When appropriate (data missing completely at random) the method &#x0201c;last observation carried forward&#x0201d; will be applied. The treatment effects will be analyzed with multivariate repeated measure ANOVAS with the within-subject factor &#x0201c;time&#x0201d; (five levels: T1 to T5) and the between-subject factor &#x0201c;group&#x0201d; (NF vs. SM; PE vs. PE+SU). Effect sizes will be reported with <italic>&#x003b7;</italic><sup>2</sup> = 0.039 defining a small, <italic>&#x003b7;</italic><sup>2</sup> = 0.110 a medium, and <italic>&#x003b7;</italic><sup>2</sup> = 0.200 a large effect. Gender and stimulant medications are important control variables, as well as treatment response according to primary outcomes. All analyses will be performed with SPSS 20 (SPSS Inc, Chicago, Il, USA).</p><sec id="s3-6-1"><title>Sample size</title><p>The primary outcome is the difference in the severity of ADHD symptoms in the Conners 3&#x000a9; rating scales for parents and teachers between the four treatment conditions (NF+PE vs. SM+PE vs. NF+PE+SU vs. SM+PE+SU) at the end of treatment (T3) and follow-up assessments (T4 and T5). ITT analyses as described will be performed. Meta-analyses report medium to large effect-sizes for behavioral ADHD interventions (Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>; Sonuga-Barke et al., <xref rid="B96" ref-type="bibr">2013</xref>) as well as for NF (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>, <xref rid="B8" ref-type="bibr">2014</xref>). Sonuga-Barke et al. (<xref rid="B96" ref-type="bibr">2013</xref>, p. 1) state that when the best probably blinded assessment is employed, effect sizes were substantially attenuated to non-significant levels for all treatments except for free fatty acid supplementation and artificial food color exclusion. On the other hand, the meta-analyses by Fabiano et al. (<xref rid="B32" ref-type="bibr">2009</xref>) and Arns et al. (<xref rid="B7" ref-type="bibr">2009</xref>) have demonstrated homogeneous and robust effects for behavioral treatments and NF protocols, so that we expect medium to large effect sizes for parent ratings of ADHD and somewhat smaller effect sizes for teacher ratings. Thus, with an assumed effect size of <italic>f</italic> = 0.25, a two-sided alpha of 0.05, a power of 0.80, four groups (NF+ PE/NF+PE+SU; SM+PE/SM+PE+SU) and five measurement time points, a total of 97 children needs to be included (GPower&#x000a9; <italic>&#x003bb;</italic> = 18.18, critical <italic>F</italic> = 1.78, numerator df = 12.00, denominator df = 276, <italic>n</italic> = 97, power = 0.80, Pillai V = 0.17). In order to adjust for loss of power due to an anticipated dropout of 20%, 120 children will be included in the study. Since the study is quite time consuming and the follow-up assessment fairly extensive, it seems likely that not all families will follow through with the whole study.</p></sec></sec><sec id="s3-7"><title>Ethical review and trial registration</title><p>This RCT has been reviewed and approved by the local review board of the Department of Psychology of the Philipps-University Marburg (AZ: 2010-04). It is registered at www.clinicaltrials.gov as NCT01879644.</p></sec><sec id="s3-8"><title>Preliminary results</title><p>From February 2011 till August 2014 a total of 74 children have been screened for the study so far. Of those, 69 fulfilled study entry criteria, but 11 dropped out of the study. Thus, a total of 58 children (83% boys) has completed the diagnostic study procedure (mean age 8.42 (SD 1.34), mean IQ 110 (SD 13.37); 23% on medication; 48% with comorbid diagnoses such as ODD, Tic Disorders, Enuresis, Sibling Rivalry Disorder, Separation Anxiety Disorder). Of those, <italic>n</italic> = 32 children have already completed the T3 and <italic>n</italic> = 17 the T4 assessments. Effects of parent training groups cannot be reported here, since number of participants of the four groups is overall too small for analyses (<italic>n</italic> &#x0003c; 10 per group). Thus, preliminary data is only reported on the whole sample and for a comparison of children in the NF vs. the SM group.</p><p>An ANOVA on the whole sample with repeated measures shows significant differences between T1 and T3 scores for the Conners&#x02019; parent and teacher ratings: main effect time = <italic>F</italic><sub>(1,35)</sub> = 17.31, <italic>p</italic> &#x0003c; 0.001, <italic>&#x003b7;</italic><sup>2</sup> = 0.331. For details for the different subscales, please refer to Table <xref ref-type="table" rid="T2A">2A</xref>.</p><table-wrap id="T2A" position="float"><label>Table 2A</label><caption><p><bold>Conners-3 T1 and T3 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores, <italic>F</italic>- and <italic>p</italic>-values and <italic>&#x003b7;</italic><sup>2</sup></bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Conners-3</bold></th><th align="center" rowspan="1" colspan="1"><bold>T1</bold></th><th align="center" rowspan="1" colspan="1"><bold>T3</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>F</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>&#x003b7;</italic><sup>2</sup></bold></th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><bold><italic>N</italic> = 32**</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>N</italic> = 32**</bold></th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ADHD index parent</td><td align="char" char="." rowspan="1" colspan="1">11.75 (5.53)</td><td align="char" char="." rowspan="1" colspan="1">7.13 (5.11)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 25.23</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> &#x0003c; 0.001</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M1"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.449</td></tr><tr><td align="left" rowspan="1" colspan="1">Inattention parent</td><td align="char" char="." rowspan="1" colspan="1">29.56 (5.97)</td><td align="char" char="." rowspan="1" colspan="1">15.16 (5.73)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 21.79</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> &#x0003c; 0.001</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M2"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.413</td></tr><tr><td align="left" rowspan="1" colspan="1">H/I* parent</td><td align="char" char="." rowspan="1" colspan="1">18.78 (7.97)</td><td align="char" char="." rowspan="1" colspan="1">14.00 (6.79)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 32.61</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> &#x0003c; 0.001</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M3"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.513</td></tr><tr><td align="left" rowspan="1" colspan="1">ADHD index teacher</td><td align="char" char="." rowspan="1" colspan="1">10.59 (5.14)</td><td align="char" char="." rowspan="1" colspan="1">7.09 (5.13)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 13.74</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.001</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M4"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.307</td></tr><tr><td align="left" rowspan="1" colspan="1">Inattention teacher</td><td align="char" char="." rowspan="1" colspan="1">17.69 (4.84)</td><td align="char" char="." rowspan="1" colspan="1">14.78 (5.58)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 8.54</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.006</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.216</td></tr><tr><td align="left" rowspan="1" colspan="1">H/I* teacher</td><td align="char" char="." rowspan="1" colspan="1">16.03 (8.91)</td><td align="char" char="." rowspan="1" colspan="1">12.69 (7.92)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,31)</sub> = 6.55</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.016</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M6"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.175</td></tr></tbody></table><table-wrap-foot><p><italic>*H/I = Hyperactivity/Impulsivity</italic>.</p><p><italic>**Both SM and NF together</italic>.</p></table-wrap-foot></table-wrap><p>An ANOVA on the whole sample with repeated measures does not show significant differences between T3 and T4 scores for the Conners&#x02019; parent and teacher ratings: main effect time = <italic>F</italic><sub>(6,11)</sub> = 0.59, <italic>p</italic> = 0.73, <italic>&#x003b7;</italic><sup>2</sup> = 0.244. For details for the different subscales, please refer to Table <xref ref-type="table" rid="T2B">2B</xref>.</p><table-wrap id="T2B" position="float"><label>Table 2B</label><caption><p><bold>Conners-3 T3 and T4 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores, <italic>F</italic>- and <italic>p</italic>-values and <italic>&#x003b7;</italic><sup>2</sup></bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Conners-3</bold></th><th align="center" rowspan="1" colspan="1"><bold>T3</bold></th><th align="center" rowspan="1" colspan="1"><bold>T4</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>F</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>&#x003b7;</italic><sup>2</sup></bold></th></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><bold><italic>N</italic> = 17**</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>N</italic> = 17**</bold></th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ADHD index parent</td><td align="char" char="." rowspan="1" colspan="1">7.53 (6.23)</td><td align="char" char="." rowspan="1" colspan="1">7.41 (5.87)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.013</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.91</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M7"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Inattention parent</td><td align="char" char="." rowspan="1" colspan="1">15.41 (6.94)</td><td align="char" char="." rowspan="1" colspan="1">14.88 (6.13)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.172</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.68</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M8"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.011</td></tr><tr><td align="left" rowspan="1" colspan="1">H/I* Parent</td><td align="char" char="." rowspan="1" colspan="1">14.24 (7.79)</td><td align="char" char="." rowspan="1" colspan="1">14.06 (8.03)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.26</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.87</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M9"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">ADHD index teacher</td><td align="char" char="." rowspan="1" colspan="1">5.88 (5.52)</td><td align="char" char="." rowspan="1" colspan="1">6.12 (5.48)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.039</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.84</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M10"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Inattention teacher</td><td align="char" char="." rowspan="1" colspan="1">13.76 (5.82)</td><td align="char" char="." rowspan="1" colspan="1">13.41 (5.98)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.064</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.80</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M11"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">H/I* teacher</td><td align="char" char="." rowspan="1" colspan="1">10.69 (6.32)</td><td align="char" char="." rowspan="1" colspan="1">9.88 (8.08)</td><td align="char" char="." rowspan="1" colspan="1"><italic>F</italic><sub>(1,16)</sub> = 0.264</td><td align="char" char="." rowspan="1" colspan="1"><italic>p</italic> = 0.61</td><td align="char" char="." rowspan="1" colspan="1"><inline-formula><mml:math id="M12"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.016</td></tr></tbody></table><table-wrap-foot><p><italic>*H/I = Hyperactivity/Impulsivity</italic>.</p><p><italic>**Both SM and NF together</italic>.</p></table-wrap-foot></table-wrap><p>Comparing the NF and SM group in a preliminary ANOVA with repeated measures, there is a multivariate significant main effect time (<italic>F</italic><sub>(2,27)</sub> = 6.98, <italic>p</italic> = 0.004, <italic>&#x003b7;</italic><sup>2</sup> = 0.34), but a multivariate non-significant main effect group (<italic>F</italic><sub>(2,27)</sub> = 0.43, <italic>p</italic> = 0.64, <italic>&#x003b7;</italic><sup>2</sup> = 0.03), and a multivariate non-significant interaction time<sup>*</sup>group (<italic>F</italic><sub>(2,27)</sub> = 0.01, <italic>p</italic> = 0.81, <italic>&#x003b7;</italic><sup>2</sup> = 0.01) for the Conners ADHD-index. Table <xref ref-type="table" rid="T2C">2C</xref> shows details of the two groups. The study continues and future results with respect to the measures outlined above and to group differences will be reported based on a larger sample.</p><table-wrap id="T2C" position="float"><label>Table 2C</label><caption><p><bold>Conners-3 T1 and T3 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores for the SM and NF group, <italic>F</italic>- and <italic>p</italic>-values and <italic>&#x003b7;</italic><sup>2</sup> for the main effects time and time*group</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Conners-3</bold></th><th align="center" rowspan="1" colspan="1"><bold>Group</bold></th><th align="center" rowspan="1" colspan="1"><bold>T1</bold></th><th align="center" rowspan="1" colspan="1"><bold>T3</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>F</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-Value</bold></th><th align="center" rowspan="1" colspan="1"><bold><italic>&#x003b7;</italic><sup>2</sup></bold></th></tr></thead><tbody><tr><td align="center" rowspan="2" colspan="1">ADHD index parent</td><td align="center" rowspan="1" colspan="1">SM</td><td align="center" rowspan="1" colspan="1">13.13</td><td align="center" rowspan="1" colspan="1">7.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><italic>n</italic> = 15</td><td align="char" char="." rowspan="1" colspan="1">(4.50)</td><td align="char" char="." rowspan="1" colspan="1">(4.45)</td><td align="left" rowspan="1" colspan="1">Time*: <italic>F</italic><sub>(1,27)</sub> = 23.11</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> &#x0003c; 0.001</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M13"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.461</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NF</td><td align="center" rowspan="1" colspan="1">10.64</td><td align="center" rowspan="1" colspan="1">7.71</td><td align="left" rowspan="1" colspan="1">Time*Group*: <italic>F</italic><sub>(1,27)</sub> = 2.89</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.101</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M14"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.097</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>n</italic> = 14</td><td align="char" char="." rowspan="1" colspan="1">(6.35)</td><td align="char" char="." rowspan="1" colspan="1">(6.28)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="2" colspan="1">ADHD index teacher</td><td align="center" rowspan="1" colspan="1">SM</td><td align="center" rowspan="1" colspan="1">10.06</td><td align="center" rowspan="1" colspan="1">6.69</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><italic>n</italic> = 15</td><td align="char" char="." rowspan="1" colspan="1">(5.48)</td><td align="char" char="." rowspan="1" colspan="1">(5.37)</td><td align="left" rowspan="1" colspan="1">Time*: <italic>F</italic><sub>(1,27)</sub> = 12.99</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.001</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M15"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.325</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">NF</td><td align="center" rowspan="1" colspan="1">11.71</td><td align="center" rowspan="1" colspan="1">7.43</td><td align="left" rowspan="1" colspan="1">Time*Group*: <italic>F</italic><sub>(1,27)</sub> = 0.273</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.605</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mi>&#x003b7;</mml:mi><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></inline-formula> = 0.010</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>n</italic> = 14</td><td align="char" char="." rowspan="1" colspan="1">(4.71)</td><td align="char" char="." rowspan="1" colspan="1">(5.04)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>*Univariate effects for the ADHD index for time and time*group for the SM and NF group</italic>.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In this trial, information is collected on acceptance, feasibility, and effectiveness of behavioral treatment with either NF or SM in a high frequent outpatient setting, to establish whether NF is a treatment alternative in such a setting. To collect such information is important, since the majority of studies comparing NF to other treatments are laboratory ones, making it difficult to conclude whether such a treatment will be efficacious in a naturalistic setting. Further, the majority of studies so far was done with children either without comorbidities or stimulant treatment (Arns et al., <xref rid="B7" ref-type="bibr">2009</xref>; Fabiano et al., <xref rid="B32" ref-type="bibr">2009</xref>), but this is not the reality of families seeking help for their children with ADHD (see introduction). So far we were able to include 58 children and their parents in the study. About half the children present with comorbid disorders and 23% are on medication. Reasons for dropout of the study varied. For some families the setting was too time consuming, other families came from far away and were able to initialize support closer to home. The majority dropped out of the study at the beginning of the treatment. Detailed results on dropouts with respect to the NF and SM group, time points and an extensive discussion of the reasons will follow when the study is completed. So far, 32 children have completed the therapy, and 17 have completed the follow-up (T4) assessment according to the study protocol. Thus, our approach to recruit a natural sample and to treat this in the described setting was feasible so far.</p><p>First preliminary results of our study show positive training effects. Children in both groups (NF and SM) improve in their psychopathology ratings according to parent and teacher Conners-3 scores over time. There is no significant difference between groups (NF and SM) in changes over time. Since we assumed that NF treatment will be at least equally effective, this assumption is met. So far, those effects are stable over time, since there is no significant change in Conners-3 scores from post treatment (T3) to 6 months after treatment (T4). Since this is an ongoing study we could only include 32 children in our preliminary analysis. Thus, those results should be perceived with caution. Results on primary and secondary outcomes with respect to our research questions (i.e., group differences, long-term effects, response rates, objective measures, changes in medication etc.; see above) and for all four groups (NF/SM, PE/PE+SU) will be presented when the full data set is available. But, if this treatment in a time limited, high frequent outpatient setting (three times a week over a period of 12 weeks) continues to be as effective as our preliminary results suggest, NF training might be an additional treatment alternative for other outpatient clinics and private practices. This would contribute to an improved patient centered care for this large group of impaired children (Christiansen and R&#x000f6;hrle, <xref rid="B15" ref-type="bibr">2012</xref>).</p><p>The greatest challenge of the study so far is the high frequency of sessions. Today, the majority of children is involved in extracurricular activities and/or parental duties make appointments three times a week difficult. The total time frame (12 weeks) somewhat eased reservations towards participation though, especially the fairly fast positive experiences related to the treatment have proved to be very motivating for children and parents. Considering the many studies that demonstrated shortend delay reward gradients for children with ADHD, i.e., a preference for smaller but sooner rewards (Sagvolden, <xref rid="B83" ref-type="bibr">2000</xref>; Kuntsi et al., <xref rid="B51" ref-type="bibr">2001</xref>; Solanto et al., <xref rid="B93" ref-type="bibr">2001</xref>; Sonuga-Barke, <xref rid="B94" ref-type="bibr">2002</xref>, <xref rid="B95" ref-type="bibr">2011</xref>; Dalen et al., <xref rid="B19" ref-type="bibr">2004</xref>; Antrop et al., <xref rid="B4" ref-type="bibr">2006</xref>; Hoerger and Mace, <xref rid="B41" ref-type="bibr">2006</xref>; Bitsakou et al., <xref rid="B12" ref-type="bibr">2009</xref>; Tripp and Wickens, <xref rid="B106" ref-type="bibr">2009</xref>), this seems crucial for positive therapy effects, and indeed argues for short and frequent therapy time frames, while coming to the therapy sessions might not necessarily be perceived as rewarding.</p></sec><sec id="s5"><title>Limitations</title><p>A limitation of the study is the lack of blinding. Even though randomization and stratification of study participants are carefully done, treatment allocation is not blinded, as are of course neither children, nor parents and therapists. To meet this limitation, we decided to include likely objective outcome measures as key secondary outcomes, i.e., the Qb-Test and the KITAP. Both are computer based and assess the three ADHD core symptoms (Qb-Test: Reh et al., <xref rid="B77" ref-type="bibr">2013</xref>), and differential markers of inattention (KITAP; Drechsler et al., <xref rid="B27" ref-type="bibr">2009</xref>). Further, the probably blinded assessment in the meta-analysis by Sonuga-Barke et al. (<xref rid="B96" ref-type="bibr">2013</xref>) were teacher ADHD ratings and those are also part of the primary outcome in our study. Those strategies, along with an a priori power analysis and assessment of participants with and without medication have been suggested to optimize designs in NF research (Vollebregt et al., this Frontiers Research Topic).</p><p>All parents receive parent training. This in itself is an evidence based intervention (Bachmann et al., <xref rid="B9" ref-type="bibr">2008</xref>; Zwi et al., <xref rid="B117" ref-type="bibr">2011</xref>), and could cause confounder effects, especially since the PE part includes strategies to manage problem behavior. But, children aged seven to eleven rarely refer themselves to therapy (Kazdin, <xref rid="B49" ref-type="bibr">2003</xref>), and psychotherapy effects for children are larger, when parents are involved (Esser and Blank, <xref rid="B31" ref-type="bibr">2011</xref>). Thus, not to include parents would be against the state of the art, and would not respect the needs of parents and caregivers.<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> It might be difficult to differentiate parent training effects for the two groups. But since the PE part is identical in both groups, and the SU does receive an addition on network-analyses, we do hope to be able to discriminate effects for the two different conditions in this study.</p></sec><sec sec-type="conclusion" id="s6"><title>Conclusion</title><p>Despite these challenges and limitations, we think that this study is a first step in establishing effective interventions in primary psycho-therapeutic care for parents and children seeking help for ADHD. According to our preliminary results, NF and SM accompanied by parent training seem to be effective in a high frequent outpatient setting. Since 23% of the children are on medication, NF and SM training effects seem to result in additional improvement. While the efficacy of psychological treatments for children has frequently been shown, the dissemination in routine care is still a problem to be solved.</p></sec><sec id="s7"><title>Author&#x02019;s contributions</title><p>Hanna Christiansen designed the study and drafted the manuscript. Verena Reh and Martin H. Schmidt conduct the study and participated in the design of the study and performed the power analysis. Winfried Rief conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="s8"><title>Author&#x02019;s information</title><p>Hanna Christiansen, PhD, is a professor of clinical child and adolescent psychology (chair) at the University of Marburg whose main research interests are neuropsychology and treatment of ADHD, children of mentally ill parents, and prevention of mental disorders.</p><p>Verena Reh, PhD is a clinical psychologist whose main research interests are behavioral assessment methods for ADHD, and new psychological treatment options for childhood ADHD and comorbid disorders.</p><p>Martin H. Schmidt is a psychologist (Dipl. -Psych.) and PhD student whose main research interests are assessment methods for ADHD in childhood and in adulthood, and new psychological treatment methods for children, adolescents, and adults with diagnosis of ADHD.</p><p>Winfried Rief, PhD, is a professor of clinical psychology and psychotherapy (chair) at University of Marburg, head of the outpatient clinic for psychological interventions, and head of the postgraduate training program in cognitive-BT at University of Marburg, Germany.</p></sec><sec id="s9"><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn id="fn0001"><p><sup>1</sup><ext-link ext-link-type="uri" xlink:href="http://www.awmf.org/leitlinien/detail/ll/028-019.html">http://www.awmf.org/leitlinien/detail/ll/028-019.html</ext-link></p></fn><fn id="fn0002"><p><sup>2</sup><ext-link ext-link-type="uri" xlink:href="http://www.psychiatry.pitt.edu/research/tools-research/ksads-pl">http://www.psychiatry.pitt.edu/research/tools-research/ksads-pl</ext-link></p></fn><fn id="fn0003"><p><sup>3</sup><ext-link ext-link-type="uri" xlink:href="http://www.nice.org.uk/guidance/cg72">http://www.nice.org.uk/guidance/cg72</ext-link> (retrieved August 18th 2014).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abikoff</surname><given-names>H.</given-names></name><name><surname>Hechtman</surname><given-names>L.</given-names></name><name><surname>Klein</surname><given-names>R. G.</given-names></name><name><surname>Gallagher</surname><given-names>R.</given-names></name><name><surname>Fleiss</surname><given-names>K.</given-names></name><name><surname>Etcovitch</surname><given-names>J. O. Y.</given-names></name><etal/></person-group>. (<year>2004a</year>). <article-title>Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>43</volume>, <fpage>820</fpage>&#x02013;<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1097/01.chi.0000128797.91601.1a</pub-id><pub-id pub-id-type="pmid">15213583</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abikoff</surname><given-names>H.</given-names></name><name><surname>Hechtman</surname><given-names>L.</given-names></name><name><surname>Klein</surname><given-names>R. G.</given-names></name><name><surname>Weiss</surname><given-names>G.</given-names></name><name><surname>Fleiss</surname><given-names>K.</given-names></name><name><surname>Etcovitch</surname><given-names>J. O. Y.</given-names></name><etal/></person-group>. (<year>2004b</year>). <article-title>Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>43</volume>, <fpage>802</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1097/01.chi.0000128791.10014.ac</pub-id><pub-id pub-id-type="pmid">15213581</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anney</surname><given-names>R. J. L.</given-names></name><name><surname>Lasky-Su</surname><given-names>J.</given-names></name><name><surname>&#x000d3;&#x02019;D&#x000fa;shl&#x000e1;ine</surname><given-names>C.</given-names></name><name><surname>Kenny</surname><given-names>E.</given-names></name><name><surname>Neale</surname><given-names>B.</given-names></name><name><surname>Mulligan</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study</article-title>. <source>Am. J. Med. Genet. B Neuropsychiatr. Genet.</source>
<volume>147B</volume>, <fpage>1369</fpage>&#x02013;<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30871</pub-id><pub-id pub-id-type="pmid">18951430</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antrop</surname><given-names>I.</given-names></name><name><surname>Stock</surname><given-names>P.</given-names></name><name><surname>Vert&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Wiersema</surname><given-names>J. R.</given-names></name><name><surname>Baeyens</surname><given-names>D.</given-names></name><name><surname>Roeyers</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>ADHD and delay aversion: the influence of non-temporal stimulation on choice for delayed rewards</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>47</volume>, <fpage>1152</fpage>&#x02013;<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01619.x</pub-id><pub-id pub-id-type="pmid">17076754</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Lofthouse</surname><given-names>N.</given-names></name><name><surname>Hersch</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>X.</given-names></name><name><surname>Hurt</surname><given-names>E.</given-names></name><name><surname>Bates</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>EEG neurofeedback for ADHD double-blind sham-controlled randomized pilot feasibility trial</article-title>. <source>J. Atten. Disord.</source>
<volume>17</volume>, <fpage>410</fpage>&#x02013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1177/1087054712446173</pub-id><pub-id pub-id-type="pmid">22617866</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>D. S.</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>S. G.</given-names></name><name><surname>Wolff</surname><given-names>L. S.</given-names></name><name><surname>Acker</surname><given-names>M. M.</given-names></name></person-group> (<year>1993</year>). <article-title>The parenting scale: a measure of dysfunctional parenting in discipline situations</article-title>. <source>Psychol. Assess.</source>
<volume>5</volume>, <fpage>137</fpage>&#x02013;<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1037//1040-3590.5.2.137</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arns</surname><given-names>M.</given-names></name><name><surname>de Ridder</surname><given-names>S.</given-names></name><name><surname>Strehl</surname><given-names>U.</given-names></name><name><surname>Breteler</surname><given-names>M.</given-names></name><name><surname>Coenen</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis</article-title>. <source>Clin. EEG Neurosci.</source>
<volume>40</volume>, <fpage>180</fpage>&#x02013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1177/155005940904000311</pub-id><pub-id pub-id-type="pmid">19715181</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arns</surname><given-names>M.</given-names></name><name><surname>Heinrich</surname><given-names>H.</given-names></name><name><surname>Strehl</surname><given-names>U.</given-names></name></person-group> (<year>2014</year>). <article-title>Evaluation of neurofeedback in ADHD: the long and winding road</article-title>. <source>Biol. Psychol.</source>
<volume>95</volume>, <fpage>108</fpage>&#x02013;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsycho.2013.11.013</pub-id><pub-id pub-id-type="pmid">24321363</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachmann</surname><given-names>M.</given-names></name><name><surname>Bachmann</surname><given-names>C.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name><name><surname>Mattejat</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Efficacy of psychiatric and psychotherapeutic interventions in children and adolescents with psychiatric disorders&#x02014;a systematic evaluation of meta-analyses and reviews: part II: ADHD and conduct disorders</article-title>. <source>Z. Kinder Jugendpsychiatr. Psychother.</source>
<volume>36</volume>, <fpage>321</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1024/1422-4917.36.5.321</pub-id><pub-id pub-id-type="pmid">18791982</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbaresi</surname><given-names>W. J.</given-names></name><name><surname>Katusic</surname><given-names>S. K.</given-names></name><name><surname>Colligan</surname><given-names>R. C.</given-names></name><name><surname>Pankratz</surname><given-names>V. S.</given-names></name><name><surname>Weaver</surname><given-names>A. L.</given-names></name><name><surname>Weber</surname><given-names>K. J.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn</article-title>. <source>Arch. Pediatr. Adolesc. Med.</source>
<volume>156</volume>, <fpage>217</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1001/archpedi.156.3.217</pub-id><pub-id pub-id-type="pmid">11876664</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>I.</given-names></name><name><surname>Dor</surname><given-names>T.</given-names></name><name><surname>Neo</surname><given-names>Y.</given-names></name><name><surname>Goldzweig</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Attitudes toward Attention-Deficit Hyperactivity Disorder (ADHD) treatment: parents&#x02018; and children&#x02019;s perspecitives</article-title>. <source>J. Child Neurol.</source>
<volume>23</volume>, <fpage>1036</fpage>&#x02013;<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1177/0883073808317726</pub-id><pub-id pub-id-type="pmid">18487521</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitsakou</surname><given-names>P.</given-names></name><name><surname>Psychogiou</surname><given-names>L.</given-names></name><name><surname>Thompson</surname><given-names>M.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Delay aversion in attention deficit/hyperactivity disorder: an empirical investigation of the broader phenotype</article-title>. <source>Neuropsychologia</source>
<volume>47</volume>, <fpage>446</fpage>&#x02013;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2008.09.015</pub-id><pub-id pub-id-type="pmid">18929587</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>Oades</surname><given-names>R. D.</given-names></name><name><surname>Psychogiou</surname><given-names>L.</given-names></name><name><surname>Hauffa</surname><given-names>B. P.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Does the cortisol response to stress mediate the link between expressed emotion and oppositonal behavior in Attention-Deficit/Hyperactivity-Disorder (ADHD)?</article-title>
<source>Behav. Brain Funct.</source>
<volume>6</volume>:<fpage>45</fpage>. <pub-id pub-id-type="doi">10.1186/1744-9081-6-45</pub-id><pub-id pub-id-type="pmid">20633268</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>R&#x000f6;hrle</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). &#x0201c;<article-title>Psychische st&#x000f6;rungen des kindes- und jugendalters</article-title>,&#x0201d; in <source>Klinische Psychologie und Psychotherapie f&#x000fc;r Bachelor Studierende, Bd. I</source>, eds <person-group person-group-type="editor"><name><surname>Berking</surname><given-names>M.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name></person-group> (<publisher-loc>Berlin U. A.</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>213</fpage>&#x02013;<lpage>234</lpage>.</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Conners</surname><given-names>C. K.</given-names></name></person-group> (<year>2008</year>). <source>Conners 3rd Edition. Manual.</source>
<publisher-loc>North Tonawanda, NY</publisher-loc>: <publisher-name>Multi-Health Systems</publisher-name>.</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalen</surname><given-names>L.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name><name><surname>Hall</surname><given-names>M.</given-names></name><name><surname>Remington</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Inhibitory deficits, delay aversion and preschool AD/HD: implications for the dual pathway model</article-title>. <source>Neural Plast.</source>
<volume>11</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1155/NP.2004.1</pub-id><pub-id pub-id-type="pmid">15303301</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalsgaard</surname><given-names>S.</given-names></name><name><surname>Nielsen</surname><given-names>H. S.</given-names></name><name><surname>Simonsen</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder and other psychiatric disorders: a Danish register-based study</article-title>. <source>J. Child Adolesc. Psychopharmacol.</source>
<volume>23</volume>, <fpage>432</fpage>&#x02013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2012.0111</pub-id><pub-id pub-id-type="pmid">24015896</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>DeBeus</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). &#x0201c;<article-title>Progress in efficacy studies of EEG biofeedback for ADHD</article-title>,&#x0201d; in <conf-name>Paper Presented at the Annual Meeting of the American Psychiatric Association</conf-name> (<conf-loc>Toronto, Canada</conf-loc>).</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBeus</surname><given-names>R. J.</given-names></name><name><surname>Kaiser</surname><given-names>D. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Neurofeedback with children with attention deficit hyperactivity disorder: a randomized doubleblind placebo-controlled study</article-title>. <source>Neurofeedback Neuromodulation Tech. Appl.</source>
<volume>16</volume>, <fpage>127</fpage>&#x02013;<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-12-382235-2.00005-6</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Delmo</surname><given-names>C.</given-names></name><name><surname>Weiffenbach</surname><given-names>O.</given-names></name><name><surname>Gabriel</surname><given-names>M.</given-names></name><name><surname>Stadler</surname><given-names>C.</given-names></name><name><surname>Poustka</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <source>Diagnostisches Interview Kiddie-Sads-Present and Lifetime Version (K-SADS-PL). 5. Auflage der deutschen Forschungsversion, erweitert um ICD-10-Diagnostik.</source>
<publisher-loc>Frankfurt</publisher-loc>: <publisher-name>Klinik f&#x000fc;r Psychiatrie und Psychotherapie des Kindes-und Jugendalters</publisher-name>, <fpage>1</fpage>&#x02013;<lpage>241</lpage>.</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Domsch</surname><given-names>H.</given-names></name><name><surname>Lohaus</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <source>Elternstressfragebogen (ESF).</source>
<publisher-loc>G&#x000f6;ttingen und Bern</publisher-loc>: <publisher-name>Hogrefe</publisher-name>.</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drabick</surname><given-names>D. A. G.</given-names></name><name><surname>Gadow</surname><given-names>K. D.</given-names></name><name><surname>Sprafkin</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Co-occurrence of conduct disorder and depression in a clinic-based sample of boys with ADHD</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>47</volume>, <fpage>766</fpage>&#x02013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01625.x</pub-id><pub-id pub-id-type="pmid">16898990</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drechsler</surname><given-names>R.</given-names></name><name><surname>Rizzo</surname><given-names>P.</given-names></name><name><surname>Steinhausen</surname><given-names>H.-C.</given-names></name></person-group> (<year>2009</year>). <article-title>Zur klinischen Validit&#x000e4;t einer computergest&#x000fc;tzten Aufmerksamkeitsbatterie f&#x000fc;r Kinder (KITAP) bei 7&#x02013;10-j&#x000e4;hrigen Kindern mit ADHS: the clinical validity of a computerized test battery for attentional performance for children</article-title>. <source>Child. Dev.</source>
<volume>18</volume>, <fpage>153</fpage>&#x02013;<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1026/0942-5403.18.3.153</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drechsler</surname><given-names>R.</given-names></name><name><surname>Straub</surname><given-names>M.</given-names></name><name><surname>Doehnert</surname><given-names>M.</given-names></name><name><surname>Heinrich</surname><given-names>H.</given-names></name><name><surname>Steinhausen</surname><given-names>H.-C.</given-names></name><name><surname>Brandeis</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Controlled evaluation of a neurofeedback training of slow cortical potentials in children with Attention Deficit/Hyperactivity Disorder (ADHD)</article-title>. <source>Behav. Brain Funct.</source>
<volume>3</volume>:<fpage>35</fpage>. <pub-id pub-id-type="doi">10.1186/1744-9081-3-35</pub-id><pub-id pub-id-type="pmid">17655749</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dreis&#x000f6;rner</surname><given-names>T.</given-names></name><name><surname>Georgiadis</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Sensitivit&#x000e4;t und Spezifit&#x000e4;t computergest&#x000fc;tzter Verfahren zur Diagnostik von Aufmerksamkeitsdefizit-/Hyperaktivit&#x000e4;tsst&#x000f6;rung (ADHS) im Kindes-und Jugendalter-Die Testbatterie zur Aufmerksamkeitspr&#x000fc;fung (TAP)</article-title>. <source>Empir. Spec. Educ.</source>
<volume>1</volume>, <fpage>3</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Du Paul</surname><given-names>G. J.</given-names></name><name><surname>Barkley</surname><given-names>R. A.</given-names></name><name><surname>Connor</surname><given-names>D. F.</given-names></name></person-group> (<year>1998</year>). &#x0201c;<article-title>Stimulants</article-title>,&#x0201d; in <source>Attention Deficit Hyperactivity Disorder: A Handbbok for Diagnosis and Treatment</source>, ed <person-group person-group-type="editor"><name><surname>Barkely</surname><given-names>R. A.</given-names></name></person-group> (<publisher-loc>New York</publisher-loc>: <publisher-name>Guilford Press</publisher-name>), <fpage>510</fpage>&#x02013;<lpage>551</lpage>.</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Esser</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <source>Lehrbuch der Klinischen Psychologie u. Psychotherapie bei Kindern + Jugendlichen.</source>
<publisher-loc>Stuttgart and New York</publisher-loc>: <publisher-name>Thieme</publisher-name>.</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esser</surname><given-names>G.</given-names></name><name><surname>Blank</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Efficacy of psychotherapy with children and adolescents</article-title>. <source>Prax. Kinderpsychol. Kinderpsychiatr.</source>
<volume>60</volume>, <fpage>626</fpage>&#x02013;<lpage>638</lpage>.<pub-id pub-id-type="pmid">22145420</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabiano</surname><given-names>G. A.</given-names></name><name><surname>Pelham</surname><given-names>W. E.</given-names><suffix>Jr.</suffix></name><name><surname>Coles</surname><given-names>E. K.</given-names></name><name><surname>Gnagy</surname><given-names>E. M.</given-names></name><name><surname>Chronis-Tuscano</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>B. C.</given-names></name></person-group> (<year>2009</year>). <article-title>A meta-analysis of behavioral treatments for attentiondeficit/hyperactivity disorder</article-title>. <source>Clin. Psychol. Rev.</source>
<volume>29</volume>, <fpage>129</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.cpr.2008.11.001</pub-id><pub-id pub-id-type="pmid">19131150</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadow</surname><given-names>K. D.</given-names></name><name><surname>DeVincent</surname><given-names>C. J.</given-names></name><name><surname>Pomeroy</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>ADHD symptom subtypes in children with pervaisive developmental disorder</article-title>. <source>J. Autism Dev. Disord.</source>
<volume>36</volume>, <fpage>271</fpage>&#x02013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-005-0060-3</pub-id><pub-id pub-id-type="pmid">16477513</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gevensleben</surname><given-names>H.</given-names></name><name><surname>Holl</surname><given-names>B.</given-names></name><name><surname>Albrecht</surname><given-names>B.</given-names></name><name><surname>Schlamp</surname><given-names>D.</given-names></name><name><surname>Kratz</surname><given-names>O.</given-names></name><name><surname>Studer</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2009a</year>). <article-title>Distinct EEG effects related to neurofeedback training in children with ADHD: a randomized controlled trial</article-title>. <source>Int. J. Psychophysiol.</source>
<volume>74</volume>, <fpage>149</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2009.08.005</pub-id><pub-id pub-id-type="pmid">19712709</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gevensleben</surname><given-names>H.</given-names></name><name><surname>Holl</surname><given-names>B.</given-names></name><name><surname>Albrecht</surname><given-names>B.</given-names></name><name><surname>Schlamp</surname><given-names>D.</given-names></name><name><surname>Kratz</surname><given-names>O.</given-names></name><name><surname>Studer</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Neurofeedback training in children with ADHD: 6-month follow-up of a randomized controlled trial</article-title>. <source>Eur. Child Adolesc. Psychiatry</source>
<volume>19</volume>, <fpage>715</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-010-0109-5</pub-id><pub-id pub-id-type="pmid">20499120</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gevensleben</surname><given-names>H.</given-names></name><name><surname>Holl</surname><given-names>B.</given-names></name><name><surname>Albrecht</surname><given-names>B.</given-names></name><name><surname>Vogel</surname><given-names>C.</given-names></name><name><surname>Schlamp</surname><given-names>D.</given-names></name><name><surname>Kratz</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2009b</year>). <article-title>Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>50</volume>, <fpage>780</fpage>&#x02013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2008.02033.x</pub-id><pub-id pub-id-type="pmid">19207632</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>J.</given-names></name><name><surname>Banaschewski</surname><given-names>T.</given-names></name><name><surname>Buitelaar</surname><given-names>J.</given-names></name><name><surname>Coghill</surname><given-names>D.</given-names></name><name><surname>Danckaerts</surname><given-names>M.</given-names></name><name><surname>Dittmann</surname><given-names>R. W.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>European guidelines on managing adverse effects of medication for ADHD</article-title>. <source>Eur. Child Adolesc. Psychiatry</source>
<volume>20</volume>, <fpage>17</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-010-0140-6</pub-id><pub-id pub-id-type="pmid">21042924</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhill</surname><given-names>L. L.</given-names></name><name><surname>Halperin</surname><given-names>J. M.</given-names></name><name><surname>Abikoff</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Stimulant medications</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>38</volume>, <fpage>503</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1097/00004583-199905000-00011</pub-id><pub-id pub-id-type="pmid">10230181</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>H.</given-names></name><name><surname>Gevensleben</surname><given-names>H.</given-names></name><name><surname>Strehl</surname><given-names>U.</given-names></name></person-group> (<year>2007</year>). <article-title>Annotation: neurofeedback&#x02014;train your brain to train behavior</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>48</volume>, <fpage>3</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01665.x</pub-id><pub-id pub-id-type="pmid">17244266</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>K.</given-names></name><name><surname>Hutchinson</surname><given-names>A. D.</given-names></name><name><surname>Denson</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Nonpharmacological treatments for ADHD: a meta-analytic review</article-title>. <source>J. Atten. Disord.</source>
<volume>18</volume>, <fpage>275</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1177/1087054712444732</pub-id><pub-id pub-id-type="pmid">22647288</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoerger</surname><given-names>M. L.</given-names></name><name><surname>Mace</surname><given-names>F. C.</given-names></name></person-group> (<year>2006</year>). <article-title>A computerized test of self-control predicts classroom behavior</article-title>. <source>J. Appl. Behav. Anal.</source>
<volume>39</volume>, <fpage>147</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1901/jaba.2006.171-04</pub-id><pub-id pub-id-type="pmid">16813037</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hooley</surname><given-names>J. M.</given-names></name></person-group> (<year>1990</year>). &#x0201c;<article-title>Expressed emotion and depression</article-title>,&#x0201d; in <source>Depression and Families: Impact and Treatment</source>, ed <person-group person-group-type="editor"><name><surname>Keitner</surname><given-names>G. I.</given-names></name></person-group> (<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatry Press</publisher-name>), <fpage>57</fpage>&#x02013;<lpage>83</lpage>.</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobson</surname><given-names>A.</given-names></name><name><surname>Kikas</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Cognitive functioning in children with and without attention-deficit/hyperactivity disorder with and without comorbid learning disabilities</article-title>. <source>J. Learn. Disabil.</source>
<volume>40</volume>, <fpage>194</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1177/00222194070400030101</pub-id><pub-id pub-id-type="pmid">17518212</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>P. S.</given-names></name><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Swanson</surname><given-names>J. M.</given-names></name><name><surname>Vitiello</surname><given-names>B.</given-names></name><name><surname>Abikoff</surname><given-names>H. B.</given-names></name><name><surname>Greenhill</surname><given-names>L. L.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>3-year follow-up of the NIMH MTA study</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>46</volume>, <fpage>989</fpage>&#x02013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1097/CHI.0b013e3180686d48</pub-id><pub-id pub-id-type="pmid">17667478</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadesj&#x000f6;</surname><given-names>C.</given-names></name><name><surname>Hagglof</surname><given-names>B.</given-names></name><name><surname>Kadesj&#x000f6;</surname><given-names>B.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Attention-Deficit/Hyperactivity Disorder: review and recommendations for future research</article-title>. <source>Clin. Child Fam. Psychol. Rev.</source>
<volume>4</volume>, <fpage>183</fpage>&#x02013;<lpage>207</lpage>.</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>J.</given-names></name><name><surname>Birmaher</surname><given-names>B.</given-names></name><name><surname>Brent</surname><given-names>D.</given-names></name><name><surname>Rao</surname><given-names>U.</given-names></name><name><surname>Ryan</surname><given-names>N.</given-names></name></person-group> (<year>1996</year>). <source>Kiddie-Sads-Present and Lifetime Version (K-SADS-PL)</source>. <publisher-loc>Pittsburgh</publisher-loc>, <publisher-name>University of Pittsburgh, School of Medicine</publisher-name> Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.psychiatry.pitt.edu/sites/default/files/Documents/assessments/ksads-pl.pdf">http://www.psychiatry.pitt.edu/sites/default/files/Documents/assessments/ksads-pl.pdf</ext-link>.</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>L.</given-names></name><name><surname>Zieren</surname><given-names>N.</given-names></name><name><surname>Zotter</surname><given-names>S.</given-names></name><name><surname>Karall</surname><given-names>D.</given-names></name><name><surname>Scholl-B&#x000fc;rgi</surname><given-names>S.</given-names></name><name><surname>Haberlandt</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Predictive validity of attentional functions in differentiating children with and without ADHD: a componential analysis</article-title>. <source>Dev. Med. Child Neurol.</source>
<volume>52</volume>, <fpage>371</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2009.03560.x</pub-id><pub-id pub-id-type="pmid">20059511</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazdin</surname><given-names>A. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Psychotherapy for children and adolescents</article-title>. <source>Annu. Rev. Psychol.</source>
<volume>54</volume>, <fpage>253</fpage>&#x02013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.psych.54.101601.145105</pub-id><pub-id pub-id-type="pmid">12185210</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuntsi</surname><given-names>J.</given-names></name><name><surname>Oosterlaan</surname><given-names>J.</given-names></name><name><surname>Stevenson</surname><given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Psychological mechanisms in hyperactivity: I response inhibition deficit, working memory impairment, delay aversion, or something else?</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>42</volume>, <fpage>199</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1111/1469-7610.00711</pub-id><pub-id pub-id-type="pmid">11280416</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansbergen</surname><given-names>M. M.</given-names></name><name><surname>van Dongen-Boomsma</surname><given-names>M.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name><name><surname>Slaats-Willemse</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study</article-title>. <source>J. Neural Transm.</source>
<volume>118</volume>, <fpage>275</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-010-0524-2</pub-id><pub-id pub-id-type="pmid">21165661</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lauth</surname><given-names>G. W.</given-names></name><name><surname>Schlottke</surname><given-names>P. F.</given-names></name></person-group> (<year>2009</year>). <source>Training Mit Aufmerksamkeitsgest&#x000f6;rten Kindern.</source>
<edition>6th Edn.</edition>
<publisher-loc>Weinheim, Basel</publisher-loc>: <publisher-name>Beltz PVU</publisher-name>.</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leins</surname><given-names>U. H. T.</given-names></name><name><surname>Kaller</surname><given-names>S.</given-names></name><name><surname>Schober</surname><given-names>F.</given-names></name><name><surname>Weber</surname><given-names>C.</given-names></name><name><surname>Strehl</surname><given-names>U.</given-names></name></person-group> (<year>2006</year>). <article-title>Neurofeedback for children with ADHD: a comparison of SCP- and theta/beta-protocols</article-title>. <source>Prax. Kinderpsychol. Kinderpsychiatr.</source>
<volume>55</volume>, <fpage>384</fpage>&#x02013;<lpage>407</lpage>. <pub-id pub-id-type="pmid">16869483</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lidzba</surname><given-names>K.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>Drechsler</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <source>Conners-3D: Deutsche Adaptation der Conners 3rd Edition<sup>TM</sup> (Conners 3)<sup>TM</sup>.</source>
<publisher-loc>G&#x000f6;ttingen und Bern</publisher-loc>: <publisher-name>Hogrefe</publisher-name>.</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>EEG biofeedback therapy for ADHD: a systematic review</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>
<volume>85</volume>:<fpage>e3</fpage>
<pub-id pub-id-type="doi">10.1136/jnnp-2014-308883.34</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lofthouse</surname><given-names>N.</given-names></name><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Hurt</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Current status of neurofeedback for Attention-Deficit/Hyperactivity Disorder</article-title>. <source>Curr. Psychiatry Rep.</source>
<volume>14</volume>, <fpage>536</fpage>&#x02013;<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1007/s11920-012-0301-z</pub-id><pub-id pub-id-type="pmid">22890816</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logemann</surname><given-names>H. N.</given-names></name><name><surname>Lansbergen</surname><given-names>M. M.</given-names></name><name><surname>Van Os</surname><given-names>T. W.</given-names></name><name><surname>B&#x000f6;cker</surname><given-names>K. B.</given-names></name><name><surname>Kenemans</surname><given-names>J. L.</given-names></name></person-group> (<year>2010</year>). <article-title>The effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled study</article-title>. <source>Neurosci. Lett.</source>
<volume>479</volume>, <fpage>49</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.05.026</pub-id><pub-id pub-id-type="pmid">20478360</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malecki</surname><given-names>K. C.</given-names></name><name><surname>Demaray</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Measuring perceived social support: development of the child and adolescent social support scale (CASSS)</article-title>. <source>Psychol. Sch.</source>
<volume>39</volume>, <fpage>1</fpage>&#x02013;<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1002/pits.10004</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Malecki</surname><given-names>C. K.</given-names></name><name><surname>Demaray</surname><given-names>M. K.</given-names></name><name><surname>Elliott</surname><given-names>S. N.</given-names></name><name><surname>Nolten</surname><given-names>P. W.</given-names></name></person-group> (<year>1999</year>). <source>The Child and Adolescent Social Support Scale.</source>
<publisher-loc>DeKalb, IL</publisher-loc>: <publisher-name>Northern Illinois University</publisher-name>.</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meichenbaum</surname><given-names>D. H.</given-names></name><name><surname>Goodman</surname><given-names>J.</given-names></name></person-group> (<year>1971</year>). <article-title>Training impulsive children to talk to themselves: a means of developing self-control</article-title>. <source>J. Abnorm. Psychol.</source>
<volume>77</volume>, <fpage>115</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1037/h0030773</pub-id><pub-id pub-id-type="pmid">5550424</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>Y.</given-names></name></person-group> (<year>2001</year>). <source>Erziehung von Kindern im Kindergartenalter: Erziehungsverhalten und Kompetenz&#x000fc;berzeugungen von Eltern und der Zusammenhang zu kindlichen Verhaltensst&#x000f6;rungen.</source>
<publisher-loc>University of Braunschweig</publisher-loc>: <publisher-name>Inaugural Dissertation</publisher-name>.</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>B. S.</given-names></name><name><surname>Hinshaw</surname><given-names>S. P.</given-names></name><name><surname>Eugene Arnold</surname><given-names>L.</given-names></name><name><surname>Swanson</surname><given-names>J. M.</given-names></name><name><surname>Pelham</surname><given-names>W. E.</given-names></name><name><surname>Hechtman</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Adolescent substance use in the multimodal treatment study of Attention-Deficit/Hyperactivity Disorder (ADHD)(MTA) as a function of childhood ADHD, random assignment to childhood treatments and subsequent medication</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>52</volume>, <fpage>250</fpage>&#x02013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2012.12.014</pub-id><pub-id pub-id-type="pmid">23452682</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>B. S. G.</given-names></name><name><surname>Hinshaw</surname><given-names>S. P.</given-names></name><name><surname>Swanson</surname><given-names>J. M.</given-names></name><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Vitiello</surname><given-names>B.</given-names></name><name><surname>Jensen</surname><given-names>P. S.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>The MTA at 8 Years: prospective follow-up of children treated for combined-type ADHD in a Multisite study</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>48</volume>, <fpage>484</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1097/CHI.0b013e31819c23d0</pub-id><pub-id pub-id-type="pmid">19318991</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monastra</surname><given-names>V. J.</given-names></name><name><surname>Lynn</surname><given-names>S.</given-names></name><name><surname>Linden</surname><given-names>M.</given-names></name><name><surname>Lubar</surname><given-names>J. F.</given-names></name><name><surname>Gruzelier</surname><given-names>J.</given-names></name><name><surname>LaVaque</surname><given-names>T. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Electroencephalographic biofeedback in the treatment of Attention-Deficit/Hyperactivity Disorder</article-title>. <source>Appl. Psychophysiol. Biofeedback</source>
<volume>30</volume>, <fpage>95</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1007/s10484-005-4305-x</pub-id><pub-id pub-id-type="pmid">16013783</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriyama</surname><given-names>T. S.</given-names></name><name><surname>Polanczyk</surname><given-names>G.</given-names></name><name><surname>Caye</surname><given-names>A.</given-names></name><name><surname>Banaschweski</surname><given-names>T.</given-names></name><name><surname>Brandeis</surname><given-names>D.</given-names></name><name><surname>Rohde</surname><given-names>L. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Evidence-based information on the clinical use of neurofeedback for ADHD</article-title>. <source>Neurotherapeutics</source>
<volume>9</volume>, <fpage>588</fpage>&#x02013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-012-0136-7</pub-id><pub-id pub-id-type="pmid">22930416</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrug</surname><given-names>S.</given-names></name><name><surname>Molina</surname><given-names>B. S.</given-names></name><name><surname>Hoza</surname><given-names>B.</given-names></name><name><surname>Gerdes</surname><given-names>A. C.</given-names></name><name><surname>Hinshaw</surname><given-names>S. P.</given-names></name><name><surname>Hechtman</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes</article-title>. <source>J. Abnorm. Child Psychol.</source>
<volume>40</volume>, <fpage>1013</fpage>&#x02013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1007/s10802-012-9610-2</pub-id><pub-id pub-id-type="pmid">22331455</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>MTA Cooperative Group</collab></person-group> (<year>1999</year>). <article-title>A 14-month randomized clinical trial of treatment strategies for Attention-Deficit/Hyperactivity Disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD</article-title>. <source>Arch. Gen. Psychiatry</source>
<volume>12</volume>, <fpage>1073</fpage>&#x02013;<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.56.12.1073</pub-id><pub-id pub-id-type="pmid">10591283</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Nestoriuc</surname><given-names>Y.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name><name><surname>Martin</surname><given-names>A.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name></person-group> (<year>2011</year>). <article-title>Efficacy of neurofeedback treatment studies in ADHD: a meta-analysis</article-title>. <conf-name>Poster Presentation at the 2011 Budapest Meeting of the European Network on Hyperkinetic Disorders</conf-name>(Eunethydis) (<publisher-loc>Budapest, Hungary</publisher-loc>).</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieweg</surname><given-names>E. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Does ADHD medication stop working after 2-3 years? On the surprising but little-known follow-up of the MTA study</article-title>. <source>Tijdschr. Psychiatr.</source>
<volume>52</volume>, <fpage>245</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="pmid">20503165</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreau-Linck</surname><given-names>E.</given-names></name><name><surname>Lessard</surname><given-names>N.</given-names></name><name><surname>L&#x000e9;vesque</surname><given-names>J.</given-names></name><name><surname>Beauregard</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of neurofeedback training on inhibitory capacities in ADHD children: a single-blind, randomized, placebo-controlled study</article-title>. <source>J. Neurother.</source>
<volume>14</volume>, <fpage>229</fpage>&#x02013;<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1080/10874208.2010.501514</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>T. W.</given-names></name></person-group> (<year>2003</year>). <source>1&#x02013;2-3 Magic Effective Discipline for Children 2&#x02013;12.</source>
<publisher-loc>Glen Ellyn, Illinois</publisher-loc>: <publisher-name>ParentMagic</publisher-name>, Inc.</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>Moreau</surname><given-names>G.</given-names></name><name><surname>Guay</surname><given-names>M. C.</given-names></name><name><surname>Achim</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). &#x0201c;<article-title>Double double-blind sham study of neurofeedback treatment in children with ADHD</article-title>,&#x0201d; in <conf-name>Proceedings of the Meeting of the International Society for Neurofeedback and Research: 2006</conf-name> (<conf-loc>Atlanta, GA</conf-loc>).</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravens-Sieberer</surname><given-names>U.</given-names></name><name><surname>Bettge</surname><given-names>S.</given-names></name><name><surname>Erhart</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Lebensqualit&#x000e4;t von kindern und jugendlichen. Ergebnisse aus der pilotphase des kinder- und jugendgesundheitssuveys</article-title>. <source>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz</source> [Epub ahead of print]. <volume>46</volume>, <fpage>340</fpage>&#x02013;<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1007/s00103-002-0562-5</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravens-Sieberer</surname><given-names>U.</given-names></name><name><surname>Bullinger</surname><given-names>M.</given-names></name></person-group> (<year>1998a</year>). <article-title>Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results</article-title>. <source>Qual. Life Res.</source>
<volume>7</volume>, <fpage>399</fpage>&#x02013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1023/a:1008853819715</pub-id><pub-id pub-id-type="pmid">9691720</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravens-Sieberer</surname><given-names>U.</given-names></name><name><surname>Bullinger</surname><given-names>M.</given-names></name></person-group> (<year>1998b</year>). <article-title>News from the KINDL-Questionnaire&#x02014;A new version for adolescents</article-title>. <source>Qual. Life Res.</source>
<volume>7</volume>, <fpage>653</fpage>.</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reh</surname><given-names>V.</given-names></name><name><surname>Schmidt</surname><given-names>M. H.</given-names></name><name><surname>Lam</surname><given-names>L.</given-names></name><name><surname>Schimmelmann</surname><given-names>B. B.</given-names></name><name><surname>Hebebrand</surname><given-names>J.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Behavioral assessment of core ADHD symptoms using the QbTest</article-title>. <source>J. Atten. Disord.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1177/1087054712472981</pub-id><pub-id pub-id-type="pmid">23382579</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reh</surname><given-names>V.</given-names></name><name><surname>Schmidt</surname><given-names>M.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Preliminary evidence for altered motion tracking-based hyperactivity in ADHD siblings</article-title>. <source>Behav. Brain Funct.</source>
<volume>10</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/1744-9081-10-7</pub-id><pub-id pub-id-type="pmid">24624931</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>G.</given-names></name><name><surname>Irblich</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Testbatterie zur Aufmerksamkeitspr&#x000fc;fung f&#x000fc;r Kinder (KITAP)</article-title>. <source>Z. Entwicklungspsychol. Padagog. Psychol.</source>
<volume>39</volume>, <fpage>206</fpage>&#x02013;<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1026/0049-8637.39.4.206</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>G.</given-names></name><name><surname>Lessing</surname><given-names>T.</given-names></name><name><surname>Krampen</surname><given-names>G.</given-names></name><name><surname>Irblich</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Reliabilit&#x000e4;t und Retest-Stabilit&#x000e4;t der &#x0201c;Testbatterie zur Aufmerksamkeitspr&#x000fc;fung f&#x000fc;r Kinder&#x0201d; (KITAP) bei 6-bis 7-j&#x000e4;hrigen Kindern</article-title>. <source>Z. Neuropsychol.</source>
<volume>23</volume>, <fpage>27</fpage>&#x02013;<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1024/1016-264x/a000059</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>R&#x000f6;hrle</surname><given-names>B.</given-names></name><name><surname>Sommer</surname><given-names>G.</given-names></name><name><surname>Nestmann</surname><given-names>F.</given-names></name></person-group> (<year>1998</year>). <source>Netzwerkintervention. Fortschritte der Gemeindepsychologie und Gesundheitsf&#x000f6;rderung.</source> (Vol. 2), <publisher-loc>T&#x000fc;bingen</publisher-loc>: <publisher-name>dgvt Verlag</publisher-name>.</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;thlisberger</surname><given-names>M.</given-names></name><name><surname>Neuenschwander</surname><given-names>R.</given-names></name><name><surname>Michel</surname><given-names>E.</given-names></name><name><surname>Roebers</surname><given-names>C. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Exekutive Funktionen: Zugrundeliegende kognitive Prozesse und deren Korrelate bei Kindern im sp&#x000e4;ten Vorschulalter</article-title>. <source>Z. Entwicklungspsychol. Padagog. Psychol.</source>
<volume>42</volume>, <fpage>99</fpage>&#x02013;<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1026/0049-8637/a000010</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagvolden</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of Attention-Deficit/Hyperactivity Disorder (AD/HD)</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>24</volume>, <fpage>31</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(99)00058-5</pub-id><pub-id pub-id-type="pmid">10654658</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saile</surname><given-names>H.</given-names></name></person-group> (<year>1996</year>). <article-title>Metaanalyse zur effektivit&#x000e4;t psychologischer behandlung hyperaktiver kinder</article-title>. <source>Z. Klin. Psychol.</source>
<volume>25</volume>, <fpage>190</fpage>&#x02013;<lpage>207</lpage>.</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sattler</surname><given-names>J. M.</given-names></name></person-group> (<year>2008</year>). <source>Assessment of Children.</source>
<publisher-loc>San Diego</publisher-loc>: <publisher-name>Jerome M. Sattler, Publishing, Inc</publisher-name>.</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schachar</surname><given-names>R.</given-names></name><name><surname>Taylor</surname><given-names>E.</given-names></name><name><surname>Wieselberg</surname><given-names>M.</given-names></name><name><surname>Thorley</surname><given-names>G.</given-names></name><name><surname>Rutter</surname><given-names>M.</given-names></name></person-group> (<year>1987</year>). <article-title>Changes in family function and relationships in children who respond to Methylphenidate</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>26</volume>, <fpage>728</fpage>&#x02013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1097/00004583-198709000-00019</pub-id><pub-id pub-id-type="pmid">3667503</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schachter</surname><given-names>H. M.</given-names></name><name><surname>Pham</surname><given-names>B.</given-names></name><name><surname>King</surname><given-names>J.</given-names></name><name><surname>Langford</surname><given-names>S.</given-names></name><name><surname>Moher</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>How efficacious and safe is short-acting methylphenidate for the treatment of Attention-Deficit Disorder in children and adolescents? A meta-analysis</article-title>. <source>CMAJ</source>
<volume>165</volume>, <fpage>1475</fpage>&#x02013;<lpage>1488</lpage>. <pub-id pub-id-type="pmid">11762571</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlegelmilch</surname><given-names>F.</given-names></name><name><surname>Markert</surname><given-names>S.</given-names></name><name><surname>Berkes</surname><given-names>S.</given-names></name><name><surname>Schellhorn</surname><given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Online ocular artifact removal for dc-EEG-signals: estimation of dc-level</article-title>. <source>Biomed. Tech.</source>
<volume>49</volume>, <fpage>340</fpage>&#x02013;<lpage>341</lpage>.</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M.</given-names></name><name><surname>Reh</surname><given-names>V.</given-names></name><name><surname>Hirsch</surname><given-names>O.</given-names></name><name><surname>Rief</surname><given-names>W.</given-names></name><name><surname>Christiansen</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Assessment of ADHD symptoms and the issue of cultural variation. Are conners 3rd rating scales applicable to children and parents with migration background?</article-title>. <source>J. Atten. Disord.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1177/1087054713493319</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;ning</surname><given-names>S.</given-names></name><name><surname>Steins</surname><given-names>G.</given-names></name><name><surname>Berek</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Das Selbstkonzept von Kindern mit Aufmerksamkeitsdefizit-/Hyperaktivit&#x000e4;tsst&#x000f6;rung (ADHD) und dessen Ver&#x000e4;nderung mit Methylphenidat</article-title>. <source>Kindheit Entwicklung</source>
<volume>11</volume>, <fpage>38</fpage>&#x02013;<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1026//0942-5403.11.1.38</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semrud-Clikeman</surname><given-names>M.</given-names></name><name><surname>Bledsoe</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Updates on Attention-Deficit/Hyperactivity Disorder and learning disorders</article-title>. <source>Curr. Psychiatry Rep.</source>
<volume>13</volume>, <fpage>364</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1007/s11920-011-0211-5</pub-id><pub-id pub-id-type="pmid">21701839</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sobeh</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <source>Aufmerksamkeitsfunktionen und Ihre Entwicklung bei Vor- und Grundschulkindern.</source>
<publisher-loc>G&#x000f6;ttingen</publisher-loc>: <publisher-name>Cuvillier-Verlag</publisher-name>.</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanto</surname><given-names>M. V.</given-names></name><name><surname>Abikoff</surname><given-names>H.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E.</given-names></name><name><surname>Schachar</surname><given-names>R.</given-names></name><name><surname>Logan</surname><given-names>G. D.</given-names></name><name><surname>Wigal</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD</article-title>. <source>J. Abnorm. Child Psychol.</source>
<volume>29</volume>, <fpage>215</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010329714819</pub-id><pub-id pub-id-type="pmid">11411784</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name></person-group> (<year>2002</year>). <article-title>Psychological heterogeneity in AD/HD&#x02014;a dual pathway model of behaviour and cognition</article-title>. <source>Behav. Brain Res.</source>
<volume>130</volume>, <fpage>29</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-4328(01)00432-6</pub-id><pub-id pub-id-type="pmid">11864715</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Editorial: ADHD as a reinforcement disorder- moving from general effects to identifying (six) specific models to test</article-title>. <source>J. Child Psychol. Psychiatry</source>
<volume>52</volume>, <fpage>917</fpage>&#x02013;<lpage>918</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2011.02444.x</pub-id><pub-id pub-id-type="pmid">21793824</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonuga-Barke</surname><given-names>E. J. S.</given-names></name><name><surname>Brandeis</surname><given-names>D.</given-names></name><name><surname>Cortese</surname><given-names>S.</given-names></name><name><surname>Daley</surname><given-names>D.</given-names></name><name><surname>Ferrin</surname><given-names>M.</given-names></name><name><surname>Holtmann</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Nonpharmacological interventions for adhd: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments</article-title>. <source>Am. J. Psychiatry</source>
<volume>170</volume>, <fpage>275</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2012.12070991</pub-id><pub-id pub-id-type="pmid">23360949</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>D. S.</given-names></name><name><surname>Blum</surname><given-names>N. J.</given-names></name><name><surname>Barbaresi</surname><given-names>W. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Developmental and behavioral disorders through the life-span</article-title>. <source>Pediatrics</source>
<volume>128</volume>, <fpage>364</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2011-0266</pub-id><pub-id pub-id-type="pmid">21768324</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhausen</surname><given-names>H. C.</given-names></name><name><surname>Bisgaard</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark</article-title>. <source>Acta Psychiatr. Scand.</source>
<volume>129</volume>, <fpage>221</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1111/acps.12155</pub-id><pub-id pub-id-type="pmid">23738593</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strehl</surname><given-names>U.</given-names></name></person-group> (<year>2009</year>). <article-title>Slow cortical potentials neurofeedback</article-title>. <source>J. Neurother.</source>
<volume>13</volume>, <fpage>117</fpage>&#x02013;<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1080/10874200902885936</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strehl</surname><given-names>U.</given-names></name><name><surname>Goth</surname><given-names>G.</given-names></name><name><surname>Klinger</surname><given-names>C.</given-names></name><name><surname>Hinterberger</surname><given-names>T.</given-names></name><name><surname>Birbaumer</surname><given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>Self-regulation of slow cortical potentials: a new treatment for children with Attention-Deficit/Hyperactivity Disorder</article-title>. <source>Pediatrics</source>
<volume>118</volume>, <fpage>e1530</fpage>&#x02013;<lpage>e1540</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2005-2478</pub-id><pub-id pub-id-type="pmid">17060480</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Strehl</surname><given-names>U.</given-names></name><name><surname>Leins</surname><given-names>U.</given-names></name><name><surname>Heinrich</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). &#x0201c;<article-title>Aufmerksamkeitsdefizit-/Hyperaktivit&#x000e4;tsst&#x000f6;rung (ADHS)</article-title>,&#x0201d; in <source>BiofeedbacK Grundlagen, Indikationen, Kommunikation, Vorgehen</source>, eds <person-group person-group-type="editor"><name><surname>Rief</surname><given-names>W.</given-names></name><name><surname>Birbaumer</surname><given-names>N.</given-names></name></person-group> (<publisher-loc>Stuttgart</publisher-loc>: <publisher-name>Schattauer</publisher-name>), <fpage>238</fpage>&#x02013;<lpage>426</lpage>.</mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>J.</given-names></name><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Kraemer</surname><given-names>H.</given-names></name><name><surname>Hechtman</surname><given-names>L.</given-names></name><name><surname>Molina</surname><given-names>B.</given-names></name><name><surname>Hinshaw</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Evidence, interpretation and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA)</article-title>. <source>J. Atten. Disord.</source>
<volume>12</volume>, <fpage>15</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1177/1087054708319525</pub-id><pub-id pub-id-type="pmid">18573924</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>J. M.</given-names></name><name><surname>Kraemer</surname><given-names>H. C.</given-names></name><name><surname>Hinshaw</surname><given-names>S. P.</given-names></name><name><surname>Arnold</surname><given-names>L. E.</given-names></name><name><surname>Conners</surname><given-names>C. K.</given-names></name><name><surname>Abikoff</surname><given-names>H. B.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>40</volume>, <fpage>168</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1097/00004583-200102000-00011</pub-id><pub-id pub-id-type="pmid">11211365</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>E.</given-names></name><name><surname>Chadwick</surname><given-names>O.</given-names></name><name><surname>Heptinstall</surname><given-names>E.</given-names></name><name><surname>Danckaerts</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Hyperactivity and conduct problems as risk factors for adolescence development</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source>
<volume>35</volume>, <fpage>1213</fpage>&#x02013;<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1097/00004583-199609000-00019</pub-id><pub-id pub-id-type="pmid">8824065</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>E. A.</given-names></name><name><surname>Sandberg</surname><given-names>S.</given-names></name><name><surname>Thorley</surname><given-names>G.</given-names></name><name><surname>Giles</surname><given-names>S.</given-names></name></person-group> (<year>1991</year>). <source>The Epidemiology of Childhood Hyperactivity.</source>
<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname><given-names>G.</given-names></name><name><surname>Wickens</surname><given-names>J. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Neurobiology of ADHD</article-title>. <source>Neuropharmacology</source>
<volume>57</volume>, <fpage>579</fpage>&#x02013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.07.026</pub-id><pub-id pub-id-type="pmid">19627998</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tully</surname><given-names>L. A.</given-names></name><name><surname>Arseneault</surname><given-names>L.</given-names></name><name><surname>Caspi</surname><given-names>A.</given-names></name><name><surname>Moffitt</surname><given-names>T. E.</given-names></name><name><surname>Morgan</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Does maternal warmth moderate the effects of birth weight on twins&#x02019; Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and low IQ?</article-title>. <source>J. Consult. Clin. Psychol.</source>
<volume>72</volume>, <fpage>218</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1037/0022-006X.72.2.218</pub-id><pub-id pub-id-type="pmid">15065956</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ulberstad</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <source>QbTest Technical Manual (rev. eD).</source>
<publisher-loc>Stockholm, Sweden</publisher-loc>: <publisher-name>Qbtech AB</publisher-name>.</mixed-citation></ref><ref id="B109"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>U.S. Department of Health and Human Services. Mental Health</collab></person-group> (<year>1999</year>). <source>A Report of the Surgeon General.</source>
<publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Adminstration, Center for Mental Health Services, Nation Institutes of Health, National Institute of Mental Health.</publisher-name></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vakil</surname><given-names>E.</given-names></name><name><surname>Blachstein</surname><given-names>H.</given-names></name><name><surname>Wertman-Elad</surname><given-names>R.</given-names></name><name><surname>Greenstein</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Verbal learning and memory as measured by the rey-auditory verbal learning test: ADHD with and without learning disabilities</article-title>. <source>Child Neuropsychol.</source>
<volume>18</volume>, <fpage>449</fpage>&#x02013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1080/09297049.2011.613816</pub-id><pub-id pub-id-type="pmid">21962025</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Loo-Neus</surname><given-names>G. H. H.</given-names></name><name><surname>Rommelse</surname><given-names>N.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name></person-group> (<year>2011</year>). <article-title>To stop or not to stop? How long should medication treatment of Attention-Deficit Hyperactivity Disorder be extended?</article-title>. <source>Eur. Neuropsychopharmacol.</source>
<volume>21</volume>, <fpage>584</fpage>&#x02013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2011.03.008</pub-id><pub-id pub-id-type="pmid">21530185</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Oord</surname><given-names>S.</given-names></name><name><surname>Prins</surname><given-names>P. J.</given-names></name><name><surname>Oosterlaan</surname><given-names>J.</given-names></name><name><surname>Emmelkamp</surname><given-names>P. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a metaanalysis</article-title>. <source>Clin. Psychol. Rev.</source>
<volume>28</volume>, <fpage>783</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.cpr.2007.10.007</pub-id><pub-id pub-id-type="pmid">18068284</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>S. N.</given-names></name><name><surname>Lesesne</surname><given-names>C. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Mental health in the United States: prevalence of diagnosis and medication treatment for Attention-Deficit Hyperactivity Disorder: United States</article-title>. <source>MMWR Morb. Mortal. Wkly. Rep.</source>
<volume>54</volume>, <fpage>842</fpage>&#x02013;<lpage>847</lpage>.</mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whalen</surname><given-names>C. K.</given-names></name><name><surname>Henker</surname><given-names>B.</given-names></name></person-group> (<year>1991</year>). <article-title>Therapies for hyperactive children: comparisons, combinations and compromises</article-title>. <source>J. Consult. Clin. Psychol.</source>
<volume>59</volume>, <fpage>126</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1037/0022-006X.59.1.126</pub-id><pub-id pub-id-type="pmid">2002128</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willcutt</surname><given-names>E. G.</given-names></name><name><surname>Pennington</surname><given-names>B. F.</given-names></name><name><surname>Oson</surname><given-names>R. K.</given-names></name><name><surname>Chhabildas</surname><given-names>N.</given-names></name><name><surname>Huslander</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuropsychological analyses of comorbidity between reading disability and attention deficit hyperactivity disorder: in search of the common deficit</article-title>. <source>Dev. Neuropsychol.</source>
<volume>27</volume>, <fpage>35</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1207/s15326942dn2701_3</pub-id><pub-id pub-id-type="pmid">15737942</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>P.</given-names></name><name><surname>Gondan</surname><given-names>M.</given-names></name><name><surname>Fimm</surname><given-names>B.</given-names></name></person-group> (<year>2002</year>). <source>KITAP Testbatterie zur Aufmerksamkeitspr&#x000fc;fung F&#x000fc;r Kinder.</source>
<publisher-loc>Herzogenrath</publisher-loc>: <publisher-name>Psychologische Testsysteme</publisher-name>.</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwi</surname><given-names>M.</given-names></name><name><surname>Jones</surname><given-names>H.</given-names></name><name><surname>Thorgaard</surname><given-names>C.</given-names></name><name><surname>York</surname><given-names>A.</given-names></name><name><surname>Dennis</surname><given-names>J. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years</article-title>. <source>Cochrane Database Syst. Rev.</source>
<volume>2011</volume>:<fpage>CD003018</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD003018.pub3</pub-id><pub-id pub-id-type="pmid">22161373</pub-id></mixed-citation></ref></ref-list></back></article>